Podcasts about feinstein institutes

Scientific Sense ® by Gill Eapen: Prof. Kevin Tracey is Professor of Molecular Medicine and Neurosurgery at Hofstra/Northwell. He is also the CEO of Feinstein Institutes for Medical Research. His latest book is Great Nerve. Please subscribe to this channel:https://www.youtube.com/c/ScientificSense?sub_confirmation=1

Lindsay Salguero-Lopez, 43, and Thomas Tartaglia, 64, share a love for kayaking, just one of the many activities both are now able to enjoy freely after receiving life-saving lung transplants. On this episode, they detail the realities of life before and after transplant, from the physical limitations and emotional toll of their conditions to the rigorous post-transplant care, lifestyle adjustments and ongoing medical management. Also joined by Aldo Iacono, MD, who oversees their care through the Northwell Transplant Institute, he explains the importance of finding the right program, longevity after transplant and the challenges of organ availability. Dr. Iacono is medical director of lung transplantation at the Northwell Transplant Institute. More about lung transplant at Northwell Watch Lindsay's lung transplant Listen to the sounds of surgery and how Northwell's lung transplant program began Read more about growing a transplant program About Northwell Health Northwell Health is New York State's largest healthcare provider and private employer, with 21 hospitals, 850 outpatient facilities and more than 16,600 affiliated physicians. We're making breakthroughs in medicine at the Feinstein Institutes for Medical Research. We're training the next generation of medical professionals at the visionary Donald and Barbara Zucker School of Medicine at Hofstra/Northwell and the Hofstra Northwell School of Nursing and Physician Assistant Studies. For information on our more than 100 medical specialties, visit Northwell.edu and follow us @NorthwellHealth on Facebook, Instagram, X and LinkedIn. Get the latest news and insights from our experts in the Northwell Newsroom: Press releases Insights Podcasts Publications Interested in a career at Northwell Health? Visit http://bit.ly/2Z7iHFL and explore our many opportunities. Get more expert insights from leading experts in the field — Northwell Newsroom.  Watch episodes of 20-Minute Health Talk on YouTube.  For information on our more than 100 medical specialties, visit Northwell.edu and follow us @NorthwellHealth on Facebook, Instagram, X and LinkedIn. Interested in a career at Northwell Health? Visit http://bit.ly/2Z7iHFL and explore our many opportunities.  

When Covid-19 first hit New York City, hospitals faced unprecedented patient surges. Queens, in particular, became an epicenter, overwhelming local facilities. Northwell Health's John D'Angelo, MD, then operations chief for the Covid Command Center, recognized the urgent need to distribute this burden more evenly across the system. His solution: load-balancing. In Part 2 of this three-part conversation, you'll hear how load balancing helped Northwell hospitals manage months-long surges and served as a model for other health systems. You'll also hear from Mangala Narasimhan, DO who, like Dr. D'Angelo, played a pivotal role in Northwell's response to the Covid-19 pandemic. Five years later, they sat down with Sandra Lindsay, RN, to reflect on this turbulant (and traumatic) time in our history.  Meet our guests John D'Angelo, MD, Executive Vice President and Market President, Northwell Health's Central Market Mangala Narasimhan, DO, Director, Critical Care Services, Northwell and medical director of the acute lung injury ECMO program This is Part 2 of their conversation. Listen to Part 1 now Check back for Part 3 on Thursday, March 13 About Northwell Health Northwell Health is New York State's largest healthcare provider and private employer, with 21 hospitals, 850 outpatient facilities and more than 16,600 affiliated physicians. We're making breakthroughs in medicine at the Feinstein Institutes for Medical Research. We're training the next generation of medical professionals at the visionary Donald and Barbara Zucker School of Medicine at Hofstra/Northwell and the Hofstra Northwell School of Nursing and Physician Assistant Studies. For information on our more than 100 medical specialties, visit Northwell.edu and follow us @NorthwellHealth on Facebook, Instagram, X and LinkedIn. Get the latest news and insights from our experts in the Northwell Newsroom: Press releases Insights Podcasts Publications Interested in a career at Northwell Health? Visit http://bit.ly/2Z7iHFL and explore our many opportunities. Get more expert insights from leading experts in the field — Northwell Newsroom.  Watch episodes of 20-Minute Health Talk on YouTube.  For information on our more than 100 medical specialties, visit Northwell.edu and follow us @NorthwellHealth on Facebook, Instagram, X and LinkedIn. Interested in a career at Northwell Health? Visit http://bit.ly/2Z7iHFL and explore our many opportunities.   Facebook –   / northwellhealth   Instagram -   / northwellhealth   X - https://www.x.com/northwellhealth LinkedIn - https://www.linkedin/northwellhealth

Colorectal cancer is the second leading cause of cancer deaths in the U.S. and, alarmingly, rates are rising in younger adults. On this 20-Minute Health Talk, Marc Greenwald, MD, discusses risk factors, symptoms, treatments and the importance of early screening. He also addresses common concerns about colonoscopy, from advances in prep to the lifesaving procedure itself, and helps listeners understand the importance of being proactive about their health.    About the expert Dr. Greenwald is chief of colorectal clinical services; surgeon-in-chief; and director of the rectal cancer program at North Shore University Hospital. About Northwell Health Northwell Health is New York State's largest healthcare provider and private employer, with 21 hospitals, 850 outpatient facilities and more than 16,600 affiliated physicians. We're making breakthroughs in medicine at the Feinstein Institutes for Medical Research. We're training the next generation of medical professionals at the visionary Donald and Barbara Zucker School of Medicine at Hofstra/Northwell and the Hofstra Northwell School of Nursing and Physician Assistant Studies. For information on our more than 100 medical specialties, visit Northwell.edu and follow us @NorthwellHealth on Facebook, Instagram, X and LinkedIn. Get the latest news and insights from our experts in the Northwell Newsroom: Press releases Insights Podcasts Publications Interested in a career at Northwell Health? Visit http://bit.ly/2Z7iHFL and explore our many opportunities. Get more expert insights from leading experts in the field — Northwell Newsroom.  Watch episodes of 20-Minute Health Talk on YouTube.  For information on our more than 100 medical specialties, visit Northwell.edu and follow us @NorthwellHealth on Facebook, Instagram, X and LinkedIn. Interested in a career at Northwell Health? Visit http://bit.ly/2Z7iHFL and explore our many opportunities.   Facebook –   / northwellhealth   Instagram -   / northwellhealth   X - https://www.x.com/northwellhealth LinkedIn - https://www.linkedin/northwellhealth

Most of us have heard of kidney transplants, and maybe even know someone who's received a kidney from a living donor — typically a family member or a friend. But did you know that living donation is also possible for livers? It's an incredible procedure, and we're diving deep into this often-overlooked life-saving option. Northwell recently launched Long Island's first living donor liver transplant program, and today we're speaking with the expert leading the charge, Nabil Dagher, MD. He'll explain how this amazing procedure works – including how the liver can actually regenerate – why it's so important, and what you need to know about the growing need for organ donors across the U.S.  About Northwell Health Northwell Health is New York State's largest healthcare provider and private employer, with 21 hospitals, 850 outpatient facilities and more than 16,600 affiliated physicians. We're making breakthroughs in medicine at the Feinstein Institutes for Medical Research. We're training the next generation of medical professionals at the visionary Donald and Barbara Zucker School of Medicine at Hofstra/Northwell and the Hofstra Northwell School of Nursing and Physician Assistant Studies. For information on our more than 100 medical specialties, visit Northwell.edu and follow us @NorthwellHealth on Facebook, Instagram, X and LinkedIn. Get the latest news and insights from our experts in the Northwell Newsroom: Press releases Insights Podcasts Publications Interested in a career at Northwell Health? Visit http://bit.ly/2Z7iHFL and explore our many opportunities. Get more expert insights from leading experts in the field — Northwell Newsroom.  Watch episodes of 20-Minute Health Talk on YouTube.  For information on our more than 100 medical specialties, visit Northwell.edu and follow us @NorthwellHealth on Facebook, Instagram, X and LinkedIn. Interested in a career at Northwell Health? Visit http://bit.ly/2Z7iHFL and explore our many opportunities.   Facebook –   / northwellhealth   Instagram -   / northwellhealth   X - https://www.x.com/northwellhealth LinkedIn - https://www.linkedin/northwellhealth

In this episode of The Aging Well Podcast, Dr. Kevin J. Tracey, a renowned pioneer in bioelectronic medicine and President and CEO of the Feinstein Institutes for Medical Research, discusses groundbreaking insights into inflammation, chronic low grade inflammation, and aging. Learn how vagus nerve stimulation could potentially reduce inflammaging, prevent disease, and revolutionize healthy aging. Dr. Tracey also shares his personal journey into bioelectronic medicine and explains the science behind vagus nerve stimulation and its potential advantages over traditional pharmacological approaches. Tune in to understand the exciting future of bioelectronic medicine and how it might transform disease prevention and aging in the next decade. Find Dr. Tracey's Book, The Great Nerve: The New Science of the Vagus Nerve and How to Harness Its Healing Reflexes at https://www.penguinrandomhouse.com/books/746339/the-great-nerve-by-kevin-j-tracey-md/ Or BUY on Amazon and support The Aging Well Podcast: https://amzn.to/3WJbXNX

Sepsis rarely attracts the attention of the public, but it's distressingly common: Every year, about 1.7 million U.S. adults develop this overreaction to infection — and more than 350,000 of them die. On this bonus episode of 20-Minute-Health-Talk, you'll hear the stories of doctors and patients fighting against this subtle yet deadly condition, and how the battle led to a global alliance to combat the silent killer. You'll also hear how pioneering research and lifesaving protocols developed at the Feinstein Institutes for Medical Research and Northwell Health have reduced sepsis-related deaths — both within their hospitals, throughout New York State, and around the world. Chapters 00:01 — Intro 00:53 — What is sepsis? 02:23 — 1985: A loss and a mission 03:36 — 2005: Assembling a team 06:08 — 2010: Launching a global alliance 06:52 — 2011: A better process 07:13 — 2012: Turning tragedy into action 08:46 — 2014: Early signs of success 10:09 — 2018: Watching the tide turn 11:06 — 2019: Broadening the effort to fight sepsis 11:34 — 2021: Tackling maternal sepsis 12:03 — 2023 and beyond: Ending sepsis 13:27 — Outro About Northwell Health Northwell Health is New York State's largest healthcare provider and private employer, with 21 hospitals, 850 outpatient facilities and more than 16,600 affiliated physicians. We're making breakthroughs in medicine at the Feinstein Institutes for Medical Research. We're training the next generation of medical professionals at the visionary Donald and Barbara Zucker School of Medicine at Hofstra/Northwell and the Hofstra Northwell School of Nursing and Physician Assistant Studies. For information on our more than 100 medical specialties, visit Northwell.edu and follow us @NorthwellHealth on Facebook, Instagram, X and LinkedIn. Get the latest news and insights from our experts in the Northwell Newsroom: Press releases Insights Podcasts Publications Interested in a career at Northwell Health? Visit http://bit.ly/2Z7iHFL and explore our many opportunities. Get more expert insights from leading experts in the field — Northwell Newsroom.  Watch episodes of 20-Minute Health Talk on YouTube.  For information on our more than 100 medical specialties, visit Northwell.edu and follow us @NorthwellHealth on Facebook, Instagram, X and LinkedIn. Interested in a career at Northwell Health? Visit http://bit.ly/2Z7iHFL and explore our many opportunities.   Facebook –   / northwellhealth   Instagram -   / northwellhealth   X - https://www.x.com/northwellhealth LinkedIn - https://www.linkedin/northwellhealth

In this special New Year's edition of 20-Minute Health Talk, host Sandra Lindsay, RN, welcomes Jaclene Jason, PhD, clinical psychologist and senior director of Behavioral Health and Addiction Services at South Oaks Hospital, to reflect on the delightful wisdom shared by kids in Northwell Health's latest TV commercial,A Little Wisdom. From embracing play to reframing fear, these young voices remind us how simple shifts in perspective can lead to a healthier, happier 2025. Dr. Jason reacts to their advice and offers practical tips to help parents embrace these ideas, fostering wellness and joy for the whole family.   About Northwell Health Northwell Health is New York State's largest healthcare provider and private employer, with 21 hospitals, 850 outpatient facilities and more than 16,600 affiliated physicians. We're making breakthroughs in medicine at the Feinstein Institutes for Medical Research. We're training the next generation of medical professionals at the visionary Donald and Barbara Zucker School of Medicine at Hofstra/Northwell and the Hofstra Northwell School of Nursing and Physician Assistant Studies. For information on our more than 100 medical specialties, visit Northwell.edu and follow us @NorthwellHealth on Facebook, Instagram, X and LinkedIn. Get the latest news and insights from our experts in the Northwell Newsroom: Press releases Insights Podcasts Publications Interested in a career at Northwell Health? Visit http://bit.ly/2Z7iHFL and explore our many opportunities. Get more expert insights from leading experts in the field — Northwell Newsroom.  Watch episodes of 20-Minute Health Talk on YouTube.  For information on our more than 100 medical specialties, visit Northwell.edu and follow us @NorthwellHealth on Facebook, Instagram, X and LinkedIn. Interested in a career at Northwell Health? Visit http://bit.ly/2Z7iHFL and explore our many opportunities.   Facebook –   / northwellhealth   Instagram -   / northwellhealth   X - https://www.x.com/northwellhealth LinkedIn - https://www.linkedin/northwellhealth

As 2024 comes to a close, we look back on five exciting medical advances coming from the Feinstein Institutes for Medical Research — the research arm of Northwell Health. In this episode, we spotlight studies that made strides in the treatment of Alzheimer's disease, lung disease, mental health and dysphagia.  Read more about these five notable Northwell advances of 2024. Chapters:   01:05 — The dark side of genetics and psychiatric disorders | Douglas F. Nixon, MD, PhD 05:21 — Sex, gender identity linked to human brain activity | Elvisha Dhamala, PhD 10:22 — Rethinking thick liquid diets | Liron Sinvani, MD 15:39 — Recognizing psychosis in Alzheimer's patients | Jeremy L. Koppel, MD 20:33 — Researchers focus on the spleen to treat the lungs | Stavros Zanos, MD PhD About Northwell Health Northwell Health is New York State's largest healthcare provider and private employer, with 21 hospitals, 850 outpatient facilities and more than 16,600 affiliated physicians. We're making breakthroughs in medicine at the Feinstein Institutes for Medical Research. We're training the next generation of medical professionals at the visionary Donald and Barbara Zucker School of Medicine at Hofstra/Northwell and the Hofstra Northwell School of Nursing and Physician Assistant Studies. For information on our more than 100 medical specialties, visit Northwell.edu and follow us @NorthwellHealth on Facebook, Instagram, X and LinkedIn. Get the latest news and insights from our experts in the Northwell Newsroom: Press releases Insights Podcasts Publications Interested in a career at Northwell Health? Visit http://bit.ly/2Z7iHFL and explore our many opportunities. Get more expert insights from leading experts in the field — Northwell Newsroom.  Watch episodes of 20-Minute Health Talk on YouTube.  For information on our more than 100 medical specialties, visit Northwell.edu and follow us @NorthwellHealth on Facebook, Instagram, X and LinkedIn. Interested in a career at Northwell Health? Visit http://bit.ly/2Z7iHFL and explore our many opportunities.   Facebook –   / northwellhealth   Instagram -   / northwellhealth   X - https://www.x.com/northwellhealth LinkedIn - https://www.linkedin/northwellhealth  

What if the key to treating chronic diseases like rheumatoid arthritis wasn't drugs but a tiny electrical device? That's the promise of vagus nerve stimulation (VNS), a groundbreaking therapy that holds the potential to transform how we approach conditions like asthma, heart disease, diabetes, obesity, and even depression and other mental health issues. On this 20-Minute Health Talk, we explore the fascinating science and remarkable potential of VNS with two leading experts: Kevin Tracey, MD, president & CEO of the Feinstein Institutes for Medical Research and the founder of bioelectronic medicine; and Murthy Simhambhatla, PhD, president & CEO of SetPoint Medical, a company pioneering cutting-edge VNS devices. Together, they discuss the history of VNS, its applications today and the potential to address a wide range of other inflammatory conditions, from multiple sclerosis to inflammatory bowel disease (IBD). They also dive into the early results of a SetPoint-led study using VNS to treat rheumatoid arthritis, which Dr. Tracey believes could be the tipping point in this over 30-year odyssey. More on vagus nerve stimulation Vagus nerve stimulation and mental health Could vagus nerve stimulation help you live longer? Inflammation 101 Vagus nerve stimulation: a weight-loss medication alternative? Using a "neural tourniquet" to control bleeding

Joining us on Well Said is Dr. Jeff Boyd, Director and Professor of the Institute of Cancer Research at the Feinstein Institutes for Medical Research and Vice President, Chief Scientific Officer, and Director of the Center for Genomic Medicine at the Northwell Health Cancer Institute to talk about the basics of cancer, the role of […]

For his work with vagus nerve stimulation as a potential hemophilia treatment, Carlos Bravo-Iñiguez, MD, PhD, has been named a 2024 STAT Wunderkind. This recognition celebrates the brightest young minds in life sciences research who are pushing the boundaries of scientific innovation. Read the full article in the Northwell Newsroom. Watch episodes of 20-Minute Health Talk on YouTube.  For information on our more than 100 medical specialties, visit Northwell.edu and follow us @NorthwellHealth on Facebook, Instagram, X and LinkedIn. Interested in a career at Northwell Health? Visit http://bit.ly/2Z7iHFL and explore our many opportunities.   Facebook –   / northwellhealth   Instagram -   / northwellhealth   X - https://www.x.com/northwellhealth LinkedIn - https://www.linkedin/northwellhealth

What's the most significant impact you can make with your career—medicine or engineering? For Sarah Kim Wandelt, PhD, this question has a personal twist! While Sarah originally set out to become a medical doctor, her career led her to the fascinating world of neuroengineering and neurotechnologies. Meanwhile, her twin sister, who had dreamed of being an engineer, is now a medical doctor. So, how did they end up switching roles, and what insights can Sarah share with aspiring professionals in neuroscience and neurotechnology? In this episode of Neurocareers: Doing the Impossible!, your Podcast Host, Dr. Milena Korostenskaja from the Institute of Neuroapproaches, interviews Dr. Sarah Wandelt on her exciting journey, from her groundbreaking work on Speech Brain–Machine Interfaces (BMIs) to her cutting-edge research on decoding internal speech signals. As a Neural Engineer at the Feinstein Institutes and a former Postdoctoral Scholar at Caltech, Sarah has been at the forefront of developing technologies that translate brain signals into speech—offering life-changing solutions for people who have lost their ability to communicate. Her publication, "Representation of internal speech by single neurons in the human supramarginal gyrus" in Nature Human Behaviour, showcases how decoding internal speech is not just a possibility but a reality. Sarah will share insights into how Brain–Machine Interfaces can decode internal speech and how her work is opening up new frontiers in neurotechnology. Curious how a career in neuroengineering can impact lives? Or how decoding the brain's inner voice is revolutionizing communication? Tune in to this episode as Sarah shares her journey, career advice, and her fascinating work in speech BMIs. Get ready for an inspiring conversation about innovation, neurotechnology, and building a career that makes a difference! About the Podcast Guest: Dr. Sarah Wandelt is a researcher specializing in Neuroprosthetics, focusing on developing technologies to restore motor and sensory function for individuals with spinal cord injuries. Her academic path began at École Polytechnique Fédérale de Lausanne, where she pursued a Master's degree in Bioengineering with a minor in Neuroprosthetics, gaining experience in non-invasive EEG and EMG devices. This foundation led to her PhD at the California Institute of Technology, where she explored the representation of grasp and speech signals in brain recordings of participants affected by spinal cord injury under the mentorship of Professor Richard Andersen. Her work involved decoding internal speech from multielectrode unit recordings from the posterior parietal cortex, earning her the Dr. Nagendranath Reddy Biological Sciences Thesis prize. Currently, as a Neural Engineer in Professor Chad Bouton's lab at the Feinstein Institutes for Medical Research, she aims to restore function and sensation in participants with spinal cord injury.     Get in touch with Sarah Wandelt, PhD: Social Media: @sarah_wandelt on X LinkedIn: Sarah Kim Wandelt https://www.linkedin.com/in/sarah-kim-wandelt-25a509b3/   Link to Representation of internal speech by single neurons in human supramarginal gyrus: https://www.nature.com/articles/s41562-024-01867-y/metrics Data and code availability: https://zenodo.org/records/10697024   Link to Decoding grasp and speech signals from the cortical grasp circuit in a tetraplegic human: https://www.sciencedirect.com/science/article/pii/S0896627322002458 Code availability: https://zenodo.org/records/6330179 Data availability: https://zenodo.org/records/7618556

Long Island is a populous island east of Manhattan in southeastern New York state, constituting a significant share of the New York metropolitan area in both population and land area. The island extends from New York Harbor 118 miles (190 km) eastward into the North Atlantic Ocean with a maximum north–south width of 23 miles (37 km).[2][3] With a land area of 1,401 square miles (3,630 km2), it is the largest island in the contiguous United States.[4] Long Island is divided among four counties, with Kings (Brooklyn), Queens, and Nassau counties occupying its western third and Suffolk County its eastern two-thirds. Long Island may refer both to the main island and the surrounding outer barrier islands. To its west, Long Island is separated from Manhattan and the Bronx by the East River tidal estuary. North of the island is Long Island Sound, across which lie Westchester County, New York, and the state of Connecticut. Across the Block Island Sound to the northeast is the state of Rhode Island. Block Island, which is part of Rhode Island, and numerous smaller islands extend farther into the Atlantic Ocean. To the extreme southwest, Long Island, at Brooklyn, is separated from Staten Island and the state of New Jersey by Upper New York Bay, The Narrows, and Lower New York Bay. With a population of 8,063,232 residents as of the 2020 U.S. census, Long Island constitutes 40% of New York state's entire population.[5][6][7][8][9] Long Island is the most populous island in any U.S. state or territory, the third-most populous island in the Americas after Hispaniola and Cuba, and the 18th-most populous island in the world ahead of Ireland, Jamaica, and Hokkaidō. Its population density is 5,859.5 inhabitants per square mile (2,262.4/km2). Long Island is culturally and ethnically diverse, featuring some of the wealthiest and most expensive neighborhoods in the world near the shorelines, as well as working-class areas in all four counties. As of 2022, Kings, Queens, Nassau, and Suffolk counties collectively had a gross domestic product of approximately $500 billion.[10] Median household income on the island significantly exceeds $100,000, and the median home price is approximately $600,000, with Nassau County approximating $700,000. Among residents over the age of 25, 42.6% hold a college degree or higher educational degree.[11] Unemployment on Long Island stays consistently below 4%. Biotechnology companies, engineering, and scientific research play a significant role in Long Island's economy,[12] including research facilities at Brookhaven National Laboratory, Cold Spring Harbor Laboratory, Stony Brook University, New York Institute of Technology, Plum Island Animal Disease Center, the New York University Tandon School of Engineering, the Zucker School of Medicine, and the Feinstein Institutes for Medical Research. As a hub of commercial aviation, Long Island is home to two of the nation's and New York metropolitan area's busiest airports, JFK International Airport and LaGuardia Airport.[a] Also located on Long Island are Long Island MacArthur Airport and two major air traffic control radar facilities, New York TRACON and New York ARTCC. Long Island has nine major bridges and thirteen navigable tunnels, which connect Brooklyn and Queens to the three other boroughs of New York City. Ferries connect Suffolk County northward across Long Island Sound to Connecticut. Long Island Rail Road is the busiest commuter railroad in North America and operates continuously.[13]

Few people know as much about inflammation and neuroscience as Dr. Kevin Tracey does. In this episode of STEM-Talk, we learn much from Tracey, who was the first to identify the inflammatory reflex, a physiological mechanism that regulates the body's immune response to injury and invasion. He is a neurosurgeon, a pioneer in bioelectrical medicine and president and CEO of the Feinstein Institutes for Medical Research in Manhasset, N.Y. The conversation in this episode covers a career spent working on “producing tomorrow's cures today” in the treatment of inflammatory diseases, including: How the death of his mother from a brain tumor when Tracey was 5 years old ultimately influenced his scientific journey. How the death of a young patient of his from sepsis further fueled his path, leading him to the insight that “good science begins with hard questions,” as Tracey shared in a TedTalk.  The molecular mechanisms of inflammation and the use of vagus nerve stimulation to treat it. His 1987 discovery of tumor necrosis factor (TNF), which contributed to a new class of drugs for inflammatory and autoimmune diseases. Another discovery that allowed him and his colleagues to merge neuroscience and immunology. His work on “The Inflammatory Reflex”, which emphasized the basic neural pathway that reflexively monitors and adjusts the inflammatory response. A sketch he drew while having lunch, which laid out how treating inflammatory diseases using a bioelectronic device might be possible. What advances in bioelectronic medicine he envisions in the next decade, and much more. [00:03:04] Dawn asks Kevin to tell the story of how he developed an interest in science that evolved into him becoming a neurosurgeon. [00:04:56] Dawn mentions that Kevin was a curious youth and asks if it is true that after getting his first car, Kevin removed the entire engine because he wanted to better understand how to do a valve job. [00:06:33] Ken mentions that after Kevin graduated from high school, he enrolled in Boston College where he earned a bachelor's degree in chemistry. Ken explains that Kevin went to Boston University Medical School for his M.D. and asks Kevin about the transition. [00:08:41] Ken asks if it is true that during Kevin's first year at medical school his classmates had better luck finding him on the golf course than in the classroom. [00:10:42] Dawn asks Kevin about his transition from medical school to the neurological surgery training program at New York Hospital, home of the Cornell University Medical College. [00:13:11] Dawn pivots to talk about sepsis, which kills more than 350,000 people annually. She asks Kevin to discuss his tragic story of treating a patient with sepsis as a young neurosurgeon and how that changed the trajectory of his career. [00:16:38] Ken explains that since the aforementioned incident, Kevin has focused on determining why septic shock occurs. Ken refers to a Ted Talk of Kevin's in which he says, “good science begins with hard questions.” Ken asks Kevin to elaborate on this point. [00:20:49] Dawn mentions that Kevin often describes himself as a brain surgeon who is fascinated by inflammation. Dawn asks Kevin how he responds when people ask him what inflammation is. [00:22:29] Ken follows up by explaining that in 1987 Kevin made progress investigating inflammation with his discovery of tumor necrosis factor (TNF), which contributed to a new class of drugs for inflammatory and autoimmune diseases. Ken asks Kevin to discuss this discovery. [00:25:56] Dawn mentions that in the late ‘90s, Kevin made another discovery that allowed him and his colleagues to merge neuroscience and immunology. Before getting into that discovery, Dawn asks Kevin to explain how humans have simple reflex circuits that harmonize the activity of our organs. She also asks him to talk about Charles Sherrington's Nobel Prize-winning research, which laid the groundwork for contemporary neuroscience by...

Can we restore movement in patients with spinal cord injuries while also bringing back the sensation they've lost? In this episode of the BCI Award Neurocareers podcast series, we dive deep into this critical question with Prof. Chad Bouton, a pioneer in neuroengineering and bioelectronic medicine. Spinal cord injuries often lead to permanent loss of movement and sensation, leaving millions worldwide with limited options for recovery. While various treatments have shown promise in restoring movement, sensation restoration remains a significant hurdle. That's where Prof. Chad Bouton and his team at Feinstein Institutes for Medical Research come in. They've developed a revolutionary technology called the Double Neural Bypass (DNB), which directly interfaces the brain, body, and spinal cord to restore lasting movement and sensation in people with paralysis. This groundbreaking work has earned them a place as one of the 12 final nominees for the prestigious BCI Award 2023. Prof. Bouton, VP of Advanced Engineering at Northwell Health, Professor, and Managing Director of the Center for Bioelectronic Medicine, has dedicated his career to pushing the boundaries of what's possible in neuroprosthetics and biomedical technology. His innovations have enabled the first paralyzed person to regain movement through brain activity alone and also advanced cancer detection methods, among other achievements. With over 70 international patents and numerous accolades, including being named Inventor of the Year at Battelle, Prof. Bouton is a leading figure in neuroengineering. In this episode, Prof. Bouton shares the story behind the Double Neural Bypass, how it works, and the incredible potential it holds for the future of neuroprosthetics. He also offers insights into his career journey and provides valuable advice for those aspiring to innovate. Whether you're fascinated by cutting-edge technology, interested in neuroprosthetics, or simply curious about the future of medical advancements, this episode is a must-listen. Tune in and discover how the Double Neural Bypass could change the lives of millions with paralysis. About the BCI Award: The International BCI Award is back, powered by g.tec medical engineering GmbH - NEVER STOP RECORDING! Don't miss your chance to be part of the cutting-edge BCI innovation! Submission Deadline: September 1st, 2024 Why Submit? Nominees will have the incredible opportunity to: Contribute a chapter to the prestigious BCI State-of-the-Art book series by Springer. Showcase their groundbreaking work at the exclusive BCI Award Ceremony. Receive coveted keynote invitations to the BCI & Neurotechnology Spring School. Ready to make your mark? Check out the submission details and criteria here: https://www.bci-award.com/Home Save the Date: Join us at the BCI Award Ceremony on October 8, 2024: https://www.bci-award.com/Home About the Podcast Host: The Neurocareers podcast is brought to you by The Institute of Neuroapproaches (https://www.neuroapproaches.org/) and its founder, Milena Korostenskaja, Ph.D. (Dr. K), a neuroscience educator, research consultant, and career coach for people in neuroscience and neurotechnologies. As a professional coach with a background in the field, Dr. K understands the unique challenges and opportunities job applicants face in this field and can provide personalized coaching and support to help you succeed. Here's what you'll get with one-on-one coaching sessions from Dr. K: Identification and pursuit of career goals Guidance on job search strategies, resume, and cover letter development Neurotech / neuroscience job interview preparation and practice Networking strategies to connect with professionals in the field of neuroscience and neurotechnologies Ongoing support and guidance to help you stay on track and achieve your goals You can always schedule a free neurocareer consultation/coaching session with Dr. K at https://neuroapproaches.as.me/free-neurocareer-consultation Subscribe to our Nerocareers Newsletter to stay on top of all our cool neurocareers news at updates https://www.neuroapproaches.org/neurocareers-news

In this episode of "ASTCT Talks," Dr. Shernan Holtan sits down with Dr. Samer Al-Homsi, as he shares his insights on the future of graft versus host disease (GVHD) prophylaxis, particularly in haploidentical transplantation. Dr. Al-Homsi delves into the innovative CAST regimen, which combines post-transplant cyclophosphamide, abatacept and short-duration tacrolimus. Learn about the challenges, breakthroughs and promising results that could revolutionize how we approach GVHD prevention and treatment, making a future without GVHD a reality. Listen in as we explore the potential for reducing transplant toxicities and the impact on patient care. About Dr. Samer Al-Homsi A. Samer Al-Homsi, MD, MBA, is the System Chief of Blood and Marrow Transplant and Cellular Therapy at Northwell Health Cancer Institute and serves as Director of Faculty and Academic Affairs in Medical Oncology. He is a Professor of Medicine at the Zucker School of Medicine and of Cancer Research at Feinstein Institutes of Medical Research. Previously, he was the Executive Director of Blood and Marrow Transplantation at NYU Grossman School of Medicine. Dr. Al-Homsi graduated from Damascus Medical School and trained in Hematology and Medical Oncology in France. He completed his residency at Advocate Health Care and fellowship at the University of Massachusetts. He has led programs in Malignant Hematology and Blood and Marrow Transplantation at several institutions, including NYU Langone Health. His research focuses on preventing graft-versus-host disease (GvHD), developing innovative approaches such as the CyBor and CAST regimens, particularly in haploidentical transplants. Dr. Al-Homsi aims to address healthcare disparities due to donor shortages among minority groups. Dr. Al-Homsi is also the President of the American Arab Assembly of Cellular Therapy and Transplantation (AAACTT), promoting collaboration among its members. About Dr. Shernan Holtan Dr. Holtan is a clinical/translational investigator. Her work focuses on increasing resilience, both at the tissue level to prevent and treat GVHD, and at the whole person level, designing exercise programs to mitigate cancer therapy-associated aging. In GVHD, her early work focused on epidermal growth factor and pregnancy hormones to facilitate tissue repair in GVHD, which led to a successful phase II study for the treatment of high-risk acute GVHD and discovery of the GVHD biomarker amphiregulin. More recently, she has led and published two prospective clinical trials regarding the use of PTCy as GVHD prophylaxis, the results of which are changing practice around the globe. Dr. Holtan has also been a competitive powerlifter, setting a national record in 2019. She has leveraged her knowledge regarding strength training into translational studies and clinical trials that are helping to reverse some of the damage done by high-dose chemotherapy and radiation. Through her multidimensional accomplishments, Dr. Holtan has demonstrated a unique and powerful intersection of medical research and physical resilience, redefining standards of care in HCT, and innovatively combating the deleterious effects of cancer treatment.

In this episode, Dr. Stavros Zanos, a renowned researcher at the Feinstein Institutes for Medical Research, discusses the potential of focused ultrasound neuromodulation in treating a wide range of cardiovascular and inflammatory diseases. Dr. Zanos explains how ultrasound activates neurons through mechanosensitive channels and shares the promising results of recent studies using neuromodulation to treat pulmonary arterial hypertension, reduce inflammatory markers, and potentially manage type 2 diabetes. Learn about the importance of precision in ultrasound neuromodulation to ensure accurate targeting of specific areas in the abdomen. This episode offers a fascinating glimpse into the future of medicine, where focused ultrasound neuromodulation could significantly impact the treatment of millions of patients worldwide.

Well Said has invited Dr. Karina Davidson, Senior Vice President of Research for Northwell Health and Director of the Institute of Health System Science at The Feinstein Institutes and Professor at the Donald and Barbara Zucker School of Medicine to assist us in understanding how to digest the reports and headlines discussing epidemiologic trends and related research findings.

As 2023 comes to a close, we look back on five exciting medical advances coming from the Feinstein Institutes for Medical Research — the research arm of Northwell Health. In the last year alone, investigators published more than 3,000 papers in peer-reviewed journals. In this episode, we spotlight studies that made strides against cancer, knee pain, paralysis, postpartum depression and inflammatory bowel disease.  Read more about these five notable Northwell advances of 2023. Chapters:   00:46 – A pill for post-partum depression | Kristina Deligiannidis, MD 05:30 – Sea coral leads to an arthritis treatment | Kenneth Zaslav, MD 11:30 – Detecting cancer early with AI | Daniel King, MD 15:20 – After paralysis, a bridge back to movement and feeling | Chad Bouton 19:08 – A stimulating solution for IBD | Benjamin Sahn, MD Northwell Health is New York State's largest healthcare provider and private employer, with 21 hospitals, 850 outpatient facilities and more than 16,600 affiliated physicians. We're making breakthroughs in medicine at the Feinstein Institutes for Medical Research. We're training the next generation of medical professionals at the visionary Donald and Barbara Zucker School of Medicine at Hofstra/Northwell and the Hofstra Northwell School of Nursing and Physician Assistant Studies. For information on our more than 100 medical specialties, visit Northwell.edu and follow us @NorthwellHealth on Facebook, Instagram, X and LinkedIn. Get the latest news and insights from our experts in the Northwell Newsroom: Press releases Insights Podcasts Publications Interested in a career at Northwell Health? Visit http://bit.ly/2Z7iHFL and explore our many opportunities.  

On today's episode, we revisit a conversation we had with two pioneers of the mRNA-based Covid-19 vaccines, Katalin Karikó, PhD, and Drew Weissman, MD, PhD. The two were just awarded the 2023 Nobel Prize in Physiology or Medicine for their groundbreaking research in messenger RNA (mRNA) technology. When we spoke with Dr. Kariko and Weissman in June 2022, they had just received the Ross Prize in Molecular Medicine. The Feinstein Institutes for Medical Research grants this honor to recognize promising careers in the fields of science and research. In this look back on that conversation, the history-making duo discusses what motivated them to endure their decades-long scientific struggles, plans to continue their mRNA research and what it means to be awarded the Ross Prize. Also on the show, we speak with Kevin Tracey, MD, president of the Feinstein Institutes for Medical Research, about the importance of supporting young scientists, early-stage research and the culture of science. Meet the experts Katalin Kariko, PhD, adjunct professor of Neurosurgery at the University of Pennsylvania and a senior vice president at BioNTech Drew Weissman, MD, PhD, the Roberts Family Professor of Vaccine Research in Penn's Perelman School of Medicine The award Drs. Kariko and Weissman received is one of six categories that are recognized each year. Since 1901, there have been 114 prizes in the Physiology or Medicine category awarded to 227 laureates.  Learn more about the Nobel Prize  Learn more about Drs. Kariko and Weissman.  More on the history of mRNA technology Learn more about the history of mRNA technology and the development of the Covid-19 vaccines on this episode of the podcast, featuring Wall Street Journal writer, Gregory Zuckerman, and two of the first Americans to receive the vaccine, Sandra Lindsay and Yves Duroseau, MD.  Watch episodes of 20-Minute Health Talk on YouTube. 

In this episode of Mommy Brain Revisited I talk with Dr. Kristina M. Deligiannidis, MD, Professor, Institute of Behavioral Science, Feinstein Institutes for Medical Research, Director, Women's Behavioral Health, Zucker Hillside Hospital, Northwell Health, Professor, Psychiatry, Molecular Medicine and Obstetrics & Gynecology, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, USA. We talk about her research on the development of neurosteroid treatments for postpartum depression. In particular we talk about her work on the new FDA approved oral medication for postpartum depression – Zuranolone as well as some practical information on Zuranolone, itself. Don't miss this episode on Mommy Brain Revisited. It's an important one for understanding the current treatment options and challenges for perinatal mental illness. For more information on Dr Deligiannidis' work and her contact information see: https://feinstein.northwell.edu/institutes-researchers/our-researchers/kristina-m-deligiannidis-md Download one of the publications that we talk about here: https://ajp.psychiatryonline.org/doi/10.1176/appi.ajp.20220785 --- Support this podcast: https://podcasters.spotify.com/pod/show/mommybrainrevisited/support

#bioelectronics #neuroscience #artificialintelligence Dr. Theo Zanos is the head of the Neural and Data Science Lab and an associate professor at the Feinstein Institutes for Medical Research and the Zucker School of Medicine at Hofstra/Northwell His thesis, supervised by Dr. Vasilis Marmarelis, focused on developing machine learning and system identification approaches for multi-input, multi-output hippocampal neural circuits to be used for a cognitive neuroprosthesis platform. https://www.linkedin.com/in/theozanoshttps://twitter.com/theozanoshttps://t.co/a1wnmKwdIQhttps://feinstein.northwell.edu/institutes-researchers/our-researchers/theodoros-zanos-phd Time Stamp 0:00 to 03:50-Intro, Bioelectronic medicine a breakthrough innovation 03:50 to 06:08- Bioelectronics vs Bioelectricity for regenerative medicine 06:08 to 10:04- Applications of bioelectronic medicine 10:04 to 15:50 - Vagus Nerve & what do we know about it 15:50 to 19:56- Tivic's Non-Invasive Vagus nerve stimulation device 19:56 to 23:49- AI/ML in Healthcare 23:49 to 30:39- Applications of AI in healthcare 30:39 to 35:50 - Brain-Computer Interface 35:50 to 40:35- BCI Healthcare applications 40:35 to 43:05- Are we living in a simulated universe 43:05 to 44:45- Noninvasive device for PTSD World trade center first responders 44:45 to 50:04- Future of Healthcare Watch our highest-viewed videos: 1-DR R VIJAYARAGHAVAN - PROF & PRINCIPAL INVESTIGATOR AT TIFR India's 1st Quantum Computer- https://youtu.be/ldKFbHb8nvQ 2-TATA MOTORS- DRIVING THE FUTURE OF MOBILITY IN INDIA- SHAILESH CHANDRA- MD: TATA MOTORS-https://youtu.be/M2Ey0fHmZJ0 3-MIT REPORT PREDICTS SOCIETAL COLLAPSE BY 2040 - GAYA HERRINGTON -DIR SUSTAINABILITY: KPMG- https://youtu.be/Jz29GOyVt04 4-WORLDS 1ST HUMAN HEAD TRANSPLANTATION- DR SERGIO CANAVERO - https://youtu.be/KY_rtubs6Lc 5-DR HAROLD KATCHER - CTO NUGENICS RESEARCH Breakthrough in Age Reversal- https://youtu.be/214jry8z3d4 6-Head of Artificial Intelligence-JIO - Shailesh Kumar https://youtu.be/q2yR14rkmZQ 7-STARTUP FROM INDIA AIMING FOR LEVEL 5 AUTONOMY - SANJEEV SHARMA CEO SWAAYATT ROBOTS - https://youtu.be/Wg7SqmIsSew 8-MAN BEHIND GOOGLE QUANTUM SUPREMACY - JOHN MARTINIS  - https://youtu.be/Y6ZaeNlVRsE 9-BANKING 4.0 - BRETT KING FUTURIST, BESTSELLING AUTHOR & FOUNDER MOVEN - https://youtu.be/2bxHAai0UG0 10-E-VTOL & HYPERLOOP- FUTURE OF INDIA" S MOBILITY- SATYANARAYANA CHAKRAVARTHY https://youtu.be/ZiK0EAelFYY 11-HOW NEUROMORPHIC COMPUTING WILL ACCELERATE ARTIFICIAL INTELLIGENCE - PROF SHUBHAM SAHAY- IIT KANPUR- https://youtu.be/sMjkG0jGCBs 12-INDIA'S QUANTUM COMPUTING INDUSTRY- PROF ARUN K PATI -DIRECTOR QETCI- https://youtu.be/Et98nkwiA8w Connect & Follow us at: https://in.linkedin.com/in/eddieavil https://in.linkedin.com/company/change-transform-india https://www.facebook.com/changetransformindia/ https://twitter.com/intothechange https://www.instagram.com/changetransformindia/ Listen to the Audio Podcast at: https://anchor.fm/transform-impossible https://podcasts.apple.com/us/podcast/change-i-m-possibleid1497201007?uo=4 https://open.spotify.com/show/56IZXdzH7M0OZUIZDb5mUZ https://www.breaker.audio/change-i-m-possible https://www.google.com/podcasts?feed=aHR0cHM6Ly9hbmNob3IuZm0vcy8xMjg4YzRmMC9wb2RjYXN0L3Jzcw Don't Forget to Subscribe www.youtube.com/@toctwpodcast

This week, Jonathan is joined by Kevin Tracey, Feinstein Institutes for Medical Research, Manhasset, New York, USA, to explore bioelectronic medicine; its use in the treatment of inflammation, including rheumatoid arthritis; and its future. The pair further dives into the vagus nerve and the link between vagotomy and Parkinson's disease, and the use of monoclonal anti-TNF antibodies to treat septic shock.  Use the following timestamps to navigate the content in this episode: (00:00)-Introduction  (02.36)-Tracey's origin story and route into medicine   (04.46)-Defining bioelectronic medicine   (07.15)-Septic shock and monoclonal anti-TNF antibodies   (10:10)-The vagus nerve and 1493  (22:15)-Vagotomy and Parkinson's disease   (26:32)-Optogenetics  (29:52)-Replacing pharmaceuticals with bioelectronics   (32:59)-Saving lives with vagus nerve stimulation to treat inflammation  (35:01)-Cancer neuroscience   (36:52)-Tracey's three wishes for improving his field of specialty 

In this episode, Eric Chang joins us to discuss making brain-body and neuro-immune connections with the vagus nerve. Ask the Expert is a ~30 minute digital cafe experience where scientists and grad students can meet and exchange with thought leaders in the field of type 1 diabetes. Link below to sign up for a seat in the cafe!  

This episode focuses on endometriosis and discusses current and new innovative ways for diagnosing this condition. Christine Metz, Donald and Barbara Zucker School of Medicine, Hempstead, New York, USA, joins Jonathan to discuss innovations in the field and the challenges around obtaining funding for women-centred conditions. Metz also discusses the ROSE study, which is investigating new ways for non-invasive diagnosis of endometriosis. Find out more about the ROSE study from the Feinstein Institutes for Medical Research and Endometriosis Foundation of America (EndoFound).  Use the following timestamps to navigate the topics discussed in this episode:  (00:00)-Introduction  (01:51)-Metz's origin story and path to endometriosis research  (04:01)-Defining moments in women's health research  (05:25)-Explaining endometriosis  (07:47)-Endometriosis research: the ROSE study  (10:57)-Delays in diagnosis  (12:44)-Recruitment for the ROSE study  (13:15)-Endometriosis awareness  (14:15)-Treatment options and accessibility  (16:58)-Award-winning research on a non-invasive diagnostic test for endometriosis  (19:28)-The ROSE II clinical trial  (20:54)-Gaps in women's health research  (22:20)-Advancing Women in Science and Medicine  (26:32)-Education and mentoring  (29:07)-Three wishes 

In this episode, Dr. Brittany Barreto talks to Professor Christine Metz, Co-Director of The ROSE Study. They discuss menstrual effluent, what it is, how it can be used as a diagnostic tool and what this means for people with endometriosis. This is an awesome episode - let us know what you think!Remember to like, rate and subscribe and enjoy the episode!Guest bioDr. Christine N Metz is a Professor at the Feinstein Institutes for Medical Research at Northwell Health and the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Her research primarily focuses on identifying mechanisms that underlie dysfunctional inflammatory responses. Most of this work centers on women's health. Dr. Metz is the author of more than 160 peer-reviewed scientific research papers and more than a dozen review articles and book chapters. She was recently recognized as one of the top 100,000 scientists in the world (among 7 million) based on her productivity and the impact of her work (PLoS Biology, 2019). Company bioThe ROSE study was developed in 2013 by Peter K Gregersen, MD and Christine N Metz, PhD, who serve as co-directors. The ROSE study enrolls menstruators ages 15-50 years to participate in research studies focused on using menstrual effluent (or menstrual blood) as a tool to study endometriosis (as well as as other uterine-health disorders). We are focused on 1) developing non-invasive methods for screening/diagnosing endometriosis (as well as uterine-health disorders) to reduce the delay in diagnosis and 2) better understanding endometriosis to develop more effective and tolerable treatments, which are sorely needed.FemTech Focus Podcast bioThe FemTech Focus Podcast is brought to you by FemHealth Insights, the leader in Women's Health market research and consulting. In this show, Dr. Brittany Barreto hosts meaningfully provocative conversations that bring FemTech experts - including doctors, scientists, inventors, and founders - on air to talk about the innovative technology, services, and products (collectively known as FemTech) that are improving women's health and wellness. Though many leaders in FemTech are women, this podcast is not specifically about female founders, nor is it geared toward a specifically female audience. The podcast gives our host, Dr. Brittany Barreto, and guests an engaging, friendly environment to learn about the past, present, and future of women's health and wellness.FemHealth Insights bioLed by a team of analysts and advisors who specialize in female health, FemHealth Insights is a female health-specific market research and analysis firm, offering businesses in diverse industries unparalleled access to the comprehensive data and insights needed to illuminate areas of untapped potential in the nuanced women's health market.Time Stamps[04:03] Professor Metz's background[06:59] What is endometriosis?[08:09] The ROSE Study[10:02] Progress in understanding endometriosis[10:53] Menstrual Effluent[12:55] The uterus is not a closed system[14:25] Research on Menstrual Effluent[17:36] How to collect Menstrual Effluent[20:23] Study findings so far[22:49] How to get involved[25:37] How quickly could a diagnosis be given with the tool?[26:15] How soon could a tool be on the market?[29:32] Attitudes to studying menstrual effluent[32:19] Funding for endometriosis research[34:23] What would be the impact if we could diagnose endometriosis earlier?[36:00] Current endometriosis treatments[38:33] What is an area of women's health and wellness that still needs innovating?[39:55] Potential law changes in Florida and the impact for endometriosis[41:22] What does the femtech industry as a whole need the most to be successful?Call To Action!Make sure you subscribe to the podcast, and if you like the show please leave us a review!Episode ContributorsProfessor Christine MetzLinkedIn: @Christine MetzTwitter: @CN_METZ The ROSE StudyWebsite: https://feinstein.northwell.edu/institutes-researchers/institute-molecular-medicine/robert-s-boas-center-for-genomics-and-human-genetics/rose-research-outsmarts-endometriosisEmail: rose@northwell.edu Feinstein Institutes for Medical Research, Northwell HealthWebsite: https://feinstein.northwell.edu/LinkedIn: @Northwell HealthTwitter: @northwellhealthInstagram: @northwellhealthYoutube: @NorthwellHealth Dr. Brittany BarretoLinkedIn: https://www.linkedin.com/in/brittanybarreto/Twitter: @DrBrittBInstagram: @drbrittanybarreto FemTech Focus PodcastWebsite: https://femtechfocus.org/LinkedIn: https://www.linkedin.com/company/femtechfocusTwitter: @FemTech_FocusInstagram: @femtechfocus FemHealth InsightsWebsite: https://www.femhealthinsights.com/LinkedIn: @FemHealth Insights

Kevin Tracey returns to the podcast to give an update about his work at the Feinstein Institutes and the work at SetPoint Medical. Top 3 Takeaways: "Two years we discovered that a drug called Famotidine, which is sold as a generic drug Pepcid AC is actually a pharmacological or a drug-based vagus nerve stimulator. And we proved first in mice that famotidine placed directly in very small amounts placed directly in the brains of mice activates the vagus nerve. And this in turn turned off cytokine storm, which of course is a big problem in Covid 19" "A company that I've co-founded, Setpoint Medical, is currently deep into clinical trials in the United States called ResetRA, which is on clinical trials.gov or on the SetPoint website for rheumatoid arthritis patients. And that trial is enrolling many patients up to, I think 250 patients will be studied according to the websites and we're hoping that goes very well. And we're hoping, I'm hoping that leads to FDA approval for vagus nerve stimulation in the US in the coming days or coming in the coming months" "I think we're very close now to vagus nerve stimulation becoming a reality for millions of patients. And I, I hope, and I see a time when patients have the. Of  choosing vagus nerve stimulation as a simple, safe therapy instead of dangerous, expensive drugs with black box warnings that are minimally effective." 0;30 "Do you wanna introduce yourself and talk about some of your work, especially as neuromodulation pertains to the immune system?" 2:45 "So the last time when we talked it was 2020. So pandemic, everything was upside down. But then you were telling me before we started recording that it was also especially busy for you at that time. So what were you up to around then?" 6:00 What were the quantitative takeaways of the Famotidine Covid trials? 8:15 "Why didn't it become standard practice?" 11:00 "You're saying the famotidine has this effect on the vagus nerve. Does this mean we no longer need vagus nerve stimulators? Can we just take Pepcid, AC?" 15:00 Do you want to talk about the Bioelectronic Medicine Summit? 17:30 What were some of the highlights of the Summit?  19:30 "You mentioned some interesting results. Is that something you can share now or is that something that we should be on the lookout for?" 21:30 "You were also featured recently in the Wall Street Journal and New York Times, what was that like and what were the articles about?" 23:15 "So what's exciting you now for 2023 and what's on the horizon for you for the next few years?" 27:15 "Is there anything that we didn't talk about that you wanted to mention?"

Well Said has invited Dr. Luca Giliberto, an Attending Neurologist at the Institute for Neurology and Neurosurgery at Northwell Health and an Assistant Professor at Feinstein Institutes for Medical Research as well as at the Zucker School of Medicine to discuss the current advancements in treating Alzheimer's disease including new drugs, their effectiveness and the safety of using them.

People with Covid-19 often get sick because the body's inflammatory response to the virus overreacts. To tamp down that inflammation, researchers at the Feinstein Institutes for Medical Research and Cold Spring Harbor Laboratory, turned their sights toward famotidine, the active ingredient in a common over-the-counter heartburn medication with anti-inflammatory potential. On this bonus episode, we speak with the lead researcher of a unique clinical trial testing the safety and efficacy of famotidine for Covid. Tobias Janowitz, MD, PhD, AN Assistant Professor, Cold Spring Harbor Laboratory and adjunct professor at the Feinstein Institutes, shares the results of the study, as well as how the pandemic impacted their approach and led to an early success story for decentralized trials, repurposing medications and the importance of collaborating with other institutions. Chapters: 00:08 - Intro 01:39 - Safety, efficacy of famotidine for Covid 02:55 - What is famotidine? 04:45 - A fully remote trial 05:58 - Virtual trial strengths, weaknesses 07:00 - Famotidine dosage for heartburn, Covid treatment 08:12 - Studying famotidine for Covid 09:10 - Decentralized clinical trials 10:56 - New paradigms, new problems 12:02 - A national focus on decentralized trials 13:16 - Collaboration supports clinical excellence This bonus episode expands on Ep. 102 featuring Onisis Stefas, PharmD, executive director of VIVO Health. Listen to that episode, available in our feed, to learn about the Covid treatments available today. More from Northwell Health Watch episodes of 20-Minute Health Talk on YouTube. For information on our more than 100 medical specialties, visit Northwell.edu. And follow us on social media: Facebook – https://www.facebook.com/northwellhealth Twitter - https://www.twitter.com/northwellhealth Instagram - https://www.instagram.com/northwellhealth/  LinkedIn - https://www.linkedin/northwellhealth  

As 2022 comes to a close, we look back on five exciting medical advances coming from clinical researchers at Northwell Health and the health system's Feinstein Institutes for Medical Research. In the last year alone, investigators published more than 2,500 papers in peer-reviewed journals. In this episode, we spotlight studies that made strides against endometriosis, diabetes, lupus, pancreatic cancer and (yes) Covid-19.  Chapters:   02:05 – Treating pancreatic cancer in a petri dish | Matthew Weiss, MD  05:51 – A powerful lupus treatment in the pipeline | Richard Furie, MD 10:25 – Famotidine for Covid | Tobias Janowitz, MD 14:45 – A noninvasive test for endometriosis | Christine Metz, MD  19:12 – Treating diabetes with ultrasound | Sangeeta Chavan, MD Meet our guests:  Matthew Weiss, MD, professor in the Institute of Cancer Research at the Feinstein Institutes and the deputy physician-in-chief and surgical director in the Cancer Institute at Northwell Health Richard Furie, MD, chief of the Division of Rheumatology at Northwell and global principal investigator on the LILAC (Part A) clinical trial Tobias Janowitz, MD, PhD, assistant professor, Cold Spring Harbor Laboratory; adjunct professor at the Feinstein Institutes; and principal investigator of the trial studying famotidine for Covid Christine Metz, PhD, professor in the Institute of Molecular Medicine at the Feinstein Institutes and co-director of Research OutSmarts Endometriosis (ROSE) study Sangeeta Chavan, PhD, professor at the Feinstein Institutes for Medical Research

Host: Jose Rubio, MD If clinicians can better understand the pathophysiology of schizophrenia, it could lead to more therapeutic options for this illness. So which potential mechanisms could be involved in its pathophysiology and in the discovery of more treatments for schizophrenia? Learn more about this illness with Dr. Jose Rubio, Assistant Professor at the Institute for Behavioral Science at the Feinstein Institutes for Medical Research.

Listen to a blog summary of a research paper published in Volume 13, entitled, "Predictive molecular biomarkers for determining neoadjuvant chemosensitivity in muscle invasive bladder cancer." _______________________________________________ Neoadjuvant chemotherapy (NAC) is a type of cancer treatment involving the administration of chemotherapy drugs before surgery. The goal of NAC is to shrink the tumor(s) in order to make it/them easier to remove during surgery and to decrease the chance of cancer recurrence after treatment. NAC is typically well tolerated by patients and has been shown to improve outcomes in patients with bladder cancer. Predictive biomarkers are being increasingly used in oncology to identify patients who are likely to respond to chemotherapy. In the past, the decision to administer chemotherapy was based on tumor type and stage. However, it is now understood that there is considerable heterogeneity within these groups, and that not all patients will respond to the same treatment. Predictive biomarkers can help to overcome this challenge by identifying those patients who are most likely to benefit from chemotherapy. There are a number of different types of predictive biomarkers, which can be divided into two broad categories: tumor biomarkers and host biomarkers. Tumor biomarkers are usually specific to the tumor type and can include markers of cell proliferation and DNA repair. Host biomarkers are usually found in the blood or other bodily fluids and can include markers of inflammation, immune function and metabolism. The use of predictive biomarkers has the potential to improve the efficacy of chemotherapy and reduce toxicity by avoiding its use in patients who are unlikely to benefit. In a new study, researchers Neal Murphy, Andrew J. Shih, Paras Shah, Oksana Yaskiv, Houman Khalili, Anthony Liew, Annette T. Lee, and Xin-Hua Zhu from Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Northwell Health Cancer Institute, Feinstein Institutes for Medical Research, and Mayo Clinic aimed to develop and validate a predictive biomarker panel for response to NAC in patients with muscle-invasive bladder cancer (MIBC). Their research paper was published on November 2, 2022, in Oncotarget's Volume 13, entitled, “Predictive molecular biomarkers for determining neoadjuvant chemosensitivity in muscle invasive bladder cancer.” Full blog - https://www.oncotarget.org/2022/11/15/biomarkers-may-predict-neoadjuvant-chemosensitivity-in-bladder-cancer/ DOI - https://doi.org/10.18632/oncotarget.28302 Correspondence to - Neal Murphy - nmurphy2@northwell.edu, Annette T. Lee - alee@northwell.edu, and Xin-Hua Zhu - xzhu1@northwell.edu Press release - https://www.oncotarget.com/index.php?journal=oncotarget&page=news&op=press&item=oncotarget-predictive-molecular-biomarkers-for-determining-neoadjuvant-chemosensitivity-in-muscle-invasive-bladder-cancer Keywords - muscle invasive bladder cancer, neoadjuvant chemotherapy, gene expression, molecular subtyping, canonical correlation analysis About Oncotarget Oncotarget is a primarily oncology-focused, peer-reviewed, open access journal. Papers are published continuously within yearly volumes in their final and complete form, and then quickly released to Pubmed. On September 15, 2022, Oncotarget was accepted again for indexing by MEDLINE. Oncotarget is now indexed by Medline/PubMed and PMC/PubMed. To learn more about Oncotarget, please visit https://www.oncotarget.com and connect with us: SoundCloud - https://soundcloud.com/oncotarget Facebook - https://www.facebook.com/Oncotarget/ Twitter - https://twitter.com/oncotarget Instagram - https://www.instagram.com/oncotargetjrnl/ YouTube - https://www.youtube.com/OncotargetYouTube LinkedIn - https://www.linkedin.com/company/oncotarget Pinterest - https://www.pinterest.com/oncotarget/ Reddit - https://www.reddit.com/user/Oncotarget/

While the Covid vaccines were developed and deployed in less than a year, the messenger RNA (mRNA) technology that powered them took more than five decades to develop. On this episode, we speak with two researchers who played a key role in advancing the science: Katalin Kariko, PhD, adjunct professor of Neurosurgery at the University of Pennsylvania and a senior vice president at BioNTech; and Drew Weissman, MD, PhD, the Roberts Family Professor of Vaccine Research in Penn's Perelman School of Medicine. Despite setbacks and even ridicule from peers, they worked tirelessly to find a way to harness the potential they saw in mRNA. In 2001, they discovered a way to turn fragile mRNA strands into viable vaccines and medicines by packaging them into lipid nanoparticles (LNPs). For their contributions to medical research, they were recently awarded the 2022 Ross Prize in Molecular Medicine, an annual award meant to cultivate promising careers in the fields of science and research.   In this episode, the history-making duo discusses what motivated them to endure their decades-long scientific struggles, their plans to continue their mRNA research and what it means to be awarded the Ross Prize. Also on the show, we speak with Kevin Tracey, MD, president of the Feinstein Institutes for Medical Research, about the importance of supporting young scientists, early-stage research, the culture of science and how listeners can nominate a candidate for the 2023 Ross Prize. Make a submission here. More on the history of mRNA technology Learn more about the history of mRNA technology and the development of the Covid-19 vaccines on this episode of the podcast, featuring Wall Street Journal writer, Gregory Zuckerman, and two of the first Americans to receive the vaccine, Sandra Lindsay and Yves Duroseau, MD.  Watch episodes of 20-Minute Health Talk on YouTube. 

Medical research often depends upon the generosity of donors: In this episode we talk to philanthropy experts about the role of donations in driving medical breakthroughs and achieving health equity across all zip codes. The panel includes: Brian Lally, senior vice president and chief development officer for Northwell Health and head of Northwell's Foundation. Mark Butler, PhD, assistant professor in the Institute of Health System Science, part of the Feinstein Institutes for Medical Research. He is leading a study using smart prescription pill bottles to help address medication adherence and reduce cardiovascular disease in the Black community. Emmet Conlon, senior vice president and group head of U.S. Healthcare and Higher Education at TD Bank, which funded Dr. Butler's clinical trial. Support our nonprofit mission and save lives. Your generous gift will allow our clinical teams to remain at the forefront of care for people in our communities.

Well Said has invited Dr. John Kane, Co-Director of the Institute of Behavioral Science, Feinstein Institutes for Medical Research and Professor of Psychiatry and Molecular Medicine at the Donald and Barbara Zucker School of Medicine to explain the ins and out of schizophrenia and the research that has improved the prognosis for many.

An interview with Dr. Jennifer Ligibel from Dana Farber Cancer Institute in Boston, MA and Dr. Catherine Alfano from Northwell Health Cancer Institute and Feinstein Institutes for Medical Research in New York, NY, co-chairs on "Exercise, Diet and Weight Management During Cancer Treatment: ASCO Guideline." This guideline addresses recommendations for exercise, diet, and weight management for adult patients undergoing active cancer treatment, highlighting where there is evidence to recommend interventions, and where future research is needed. Read the full guideline at www.asco.org/supportive-care-guidelines.   TRANSCRIPT Brittany Harvey: Hello and welcome to the ASCO Guidelines podcast series brought to you by the ASCO Podcast Network, a collection of nine programs covering a range of educational and scientific content and offering enriching insight into the world of cancer care. You can find all the shows, including this one at asco.org/podcasts. My name is Brittany Harvey, and today I'm interviewing Dr. Jennifer Ligibel from Dana Farber Cancer Institute in Boston, Massachusetts, and Dr. Catherine Alfano from Northwell Health Cancer Institute, and Feinstein Institutes for Medical Research in New York, New York, co-chairs on 'Exercise, Diet and Weight Management During Cancer Treatment: ASCO Guideline'. Thank you for being here, Dr. Ligibel and Dr. Alfano. Dr. Jennifer Ligibel: Thanks for having us. Brittany Harvey: First, I'd like to note that ASCO takes great care in the development of its guidelines and ensuring that the ASCO conflict of interest policy is followed for each guideline. The full conflict of interest information for this guideline panel is available online with the publication of the guideline in the Journal of Clinical Oncology. Dr. Ligibel, do you have any relevant disclosures that are directly related to this guideline topic? Dr. Jennifer Ligibel: I have no personal conflicts with this guideline. Brittany Harvey: Thank you. Dr. Alfano, do you have any relevant disclosures that are directly related to this guideline topic? Dr. Catherine Alfano: I have no conflicts. Brittany Harvey: Thank you. Then, getting into the content of this guideline. Dr. Ligibel, can you start us off with an overview of the scope of this guideline? Dr. Jennifer Ligibel: Sure. So, this guideline was developed to provide recommendations around exercise, diet, and weight management for patients undergoing active cancer treatment. We defined active cancer treatment as either the perioperative period or the period of time in which patients were receiving chemotherapy and/or radiation. This guideline specifically focuses on adult cancer patients and largely focuses on individuals undergoing treatment for curative intent. There were a number of reasons why we thought it was important to develop a guideline specifically for patients who were undergoing cancer treatment. There are a number of other guidelines that talk about the role of these types of lifestyle factors in preventing cancer, and also information widely available about the potential benefits of exercising more, consuming certain types of diets, or losing weight after cancer treatment is finished. But there's much less information about the feasibility and potential benefits and safety of increasing your exercise, changing your diet, or losing weight during cancer treatment. This is the time when oncology providers are primarily working with patients in a time when patients have a lot of questions about what they should be eating and what they should be doing. So, this guideline was developed to specifically try to provide guidance during treatment. Brittany Harvey: Yes, definitely an area in which guidance is very much needed. So, then Dr. Alfano, I'd like to next review the key recommendations of this guideline, starting with what are the recommendations regarding exercise during cancer treatment? Dr. Catherine Alfano: For exercise, the expert panel felt that the evidence was very strong. And so, oncology providers should recommend aerobic and resistance exercise during active treatment with curative intent because it can mitigate the side effects of cancer treatments. So, exercise has been shown during active cancer treatment to reduce fatigue, to either improve or preserve a patient's cardiorespiratory fitness, their physical functioning, their strength outcomes, and in some kinds of patients exercise has been shown to improve quality of life and reduce anxiety and depression. The evidence is not sufficient to recommend exercise specifically for improving cancer control outcomes yet. This is a source of ongoing study, but we felt that the evidence was strong enough that oncology providers should recommend aerobic and resistance exercise, and it should become the standard of care for all cancer patients. The second recommendation regarding exercise is that oncology providers may recommend pre-operative exercise for patients specifically undergoing surgery for lung cancer. So, this can be called prehab or pre-habilitation exercise. And this exercise has been shown to reduce outcomes like the length of hospital stay and postoperative complications. Brittany Harvey: Excellent. Thank you for reviewing those recommendations and the level of evidence behind them. So, then, Dr. Ligibel, what did the panel recommend regarding particular dietary patterns or foods for patients during cancer treatment? Dr. Jennifer Ligibel: One of the things that we recognized as a panel as we reviewed the evidence that shaped these guidelines was that there was much less evidence for both dietary factors and whether that was specific dietary patterns or some specific foods, as well as weight management, how those types of changes during treatment, affected outcomes, or even the feasibility of changing your diet or losing weight during cancer treatment. We, for this guideline, really relied on randomized trials to help shape our guidance, and we realized very quickly that there were few randomized trials testing dietary change or weight management during cancer treatment. So, as a panel, we debated for a long time about what we should say in this setting. We did find that there were a few randomized trials that specifically looked at neutropenic diets. We defined that as diets that omitted fresh fruits and vegetables for patients who had undergone treatment for hematologic malignancies, and in particular bone marrow transplants. Those studies were designed to look at whether those types of diets reduce the risk of infection. We did not see evidence that omitting fruits and vegetables during cancer treatment for those malignancies, reduced infection, and so the group provided a recommendation that neutropenic diets not be recommended for patients during cancer treatment, but we were unable to provide specific guidance regarding other dietary factors or the incorporation of specific foods during cancer treatment. As a group, we recognize the importance of a healthy diet for general health. But given that we were really looking at randomized trials of the effects of changing someone's diet during treatment, we ultimately did not make a recommendation for a particular diet during cancer treatment, but really called for more research with well-designed clinical trials to test the impact of things like plant-based diets, intermittent fasting, other types of diets for which there may be interesting preclinical evidence, but very little information in people about the benefits or even the safety of these types of diets during cancer treatment. Brittany Harvey: Understood, I appreciate you outlining the nuance of that recommendation, and also the areas for future research, which we can get into a little bit more in a little bit. So then, in the last category of recommendations, Dr. Alfano, what does the guideline state regarding interventions to promote intentional weight loss or avoidance of weight gain during cancer treatment? Dr. Catherine Alfano: So, when our panel reviewed the evidence for weight loss or the avoidance of weight gain during cancer treatment, unfortunately, we decided that ultimately, there's insufficient evidence right now to recommend either for or against intentional weight loss or the prevention of weight gain during active treatment to improve outcomes related to the quality of life or things like treatment toxicities, or ultimately cancer control outcomes. Brittany Harvey: Thank you, Dr. Alfano, for that recommendation, as well. So, Dr. Ligibel, in your view, what is the importance of this guideline? And how will it impact both clinicians and patients? Dr. Jennifer Ligibel: This guideline is really the first large-scale effort to pull together all of the data from randomized trials about the effects of changing your lifestyle, exercising more, in particular, changing your diet, changing your weight during cancer treatment. I think that as a panel, we found very clear and consistent evidence as Dr. Alfano outlined, that exercise has concrete benefits for patients during cancer treatment. I think that this is really an important call to action, both for providers in speaking about these topics to their patients, but also for payers. And as we think about our healthcare system, about how we're going to support patients in becoming more active in a safe way during their cancer treatment. I think that it's very important that we recognize that encouraging physical activity is not just telling people that they should go out and do it. We really need to think about how we support patients in making these types of lifestyle changes in a sustained way. So, I think that this guideline really provides clear evidence that exercise is important. It also provides clear evidence that we need more research in other areas. Patients are asking their oncology providers every day, what they should be eating, whether they should be thinking about losing weight, and we really don't have clear evidence to guide these conversations at this point. I do think it's important to recognize that as a panel, we all felt very strongly that this guideline should not be interpreted as saying that a healthy diet or maintaining a healthy weight during treatment wasn't important. But we were really struck by the dearth of high-level evidence to be able to help our patients make informed choices and I think that's something that, from this guideline, we really need to come up with a plan be better able to ask the question that comes up in the clinic every day of, 'Doctor, what should I eat?' Brittany Harvey: Those are excellent points. I appreciate the panel looking critically at the evidence that's actually out there to try and determine recommendations. So then, Dr. Ligibel just mentioned a few areas in which more research is needed. So, Dr. Alfano, what are the outstanding questions regarding optimal diet, weight management, and exercise during active cancer treatment? Dr. Catherine Alfano: Being treated for cancer makes many patients feel like they have no control over their health and that causes them enormous anxiety. Patients are really looking for things that they can do to take the reins of control back over their health to improve their long-term health and well-being during treatment. I want to underscore the importance of the oncology team in helping patients improve their exercise. Research has shown that 50% of patients undergoing cancer treatment are not getting enough exercise. Patients want to receive guidance about exercise from their oncology team. And importantly, patients whose oncology clinicians discuss exercise with them are more likely to make these healthy behavior changes. So, it really underscores the importance of the oncology team in helping patients to access these important components of their health that they're asking for. The appropriate referral for exercise in patients undergoing treatment for cancer can really depend on several factors such as comorbidities, treatment toxicities, and the patient's pre-existing physical activity level. For example, many patients can safely perform unsupervised exercise, but others may need supervised cancer-specific exercise because they've got problems that they need to deal with clinically supervised exercise or to participate in a formal cancer rehabilitation program prior to undertaking exercise on their own. I want to highlight for everyone that there are national efforts that are focusing on building referral algorithms and clinical decision support tools to help point to the most safe, feasible, and effective intervention for a given patient. Brittany Harvey: Excellent. Well, thank you both so much for outlining the recommendations here and describing the nuance that the expert panel went through. It was certainly a large effort that you've helped lead. And so, I want to thank you so much for your work on these guidelines, and for your time today, Dr. Ligibel and Dr. Alfano. Dr. Jennifer Ligibel: Thanks for having us. Dr. Catherine Alfano: Thank you. Brittany Harvey: Thank you to all of our listeners for tuning in to the ASCO guidelines podcast series. To read the full guideline go to www.asco.org/supportive-care-guidelines. You can also find many of our guidelines and interactive resources in the free ASCO Guidelines app available in iTunes or the Google Play Store. If you have enjoyed what you've heard today, please rate and review the podcast and be sure to subscribe so you never miss an episode.   The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity or therapy should not be construed as an ASCO endorsement.

Diagnosing a disease usually requires a test or blood sample. But for women with endometriosis, diagnosis requires an invasive surgery. For April Summerford, a 36-year-old from Fresno California, that surgery actually worsened her disease. Wanting to do her part, she joined the ROSE study, which stands for Research OutSmarts Endometriosis. Led by Christine Metz, PhD, and Peter Gregersen, MD, the ROSE research team has spent the last seven years trying to find better treatments and less invasive ways to detect endometriosis.   Dr. Metz and Dr. Gregersen join April to discuss her decade-long battle, the ROSE study's innovative approaches to studying endometriosis, the medical gaslighting patients often face, and the problem of gender bias in research funding.   Meet our guests Dr. Christine Metz is co-director of the study and a professor in the Institute of Molecular Medicine at the Feinstein Institutes for Medical Research. Dr. Peter Gregersen is also co-director of the ROSE study, and director of the Feinstein's Robert S. Boas Center for Genomics and Human Genetics. April Summerford, is an endometriosis patient and ROSE study participant, who also runs the popular support group, Beyond Endo; AND hosts the FemFuture podcast, which covers women's health.

In this episode of the EMEUNET podcast, we are looking back to ACR 2020. In this episode, Dr Alvise Berti interviews Prof. Betty Diamond following the Mentor-Mentee meeting, also available as a previous podcast. Prof. Diamond graduated with a BA from Harvard University and an MD from Harvard Medical School. She performed a residency in internal medicine at Columbia Presbyterian Medical Center and received postdoctoral training in immunology at the Albert Einstein College of Medicine. Prof. Diamond has headed the rheumatology divisions at Albert Einstein School of Medicine and at Columbia University Medical Center. She also directed the Medical Scientist Training Program at Albert Einstein School of Medicine for many years. She is currently head of the Center for Autoimmune, Musculoskeletal and Hematopoietic Diseases at The Feinstein Institutes for Medical Research and director of the PhD and MD/PhD programs of the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. A former president of the American Association of Immunology, Prof. Diamond has also served on the Board of Directors of the American College of Rheumatology and the Scientific Council of the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). Here, she shares some of her experiences in the field of medical research, especially in lupus, and her thoughts on future research in this area.

My guests on this episode Dr. Peter Gregersen and Dr. Christine Metz are Co-Directors of the ROSE Study at Northwell Health. The ROSE research team is a group of Feinstein Institutes scientists and professionals who are currently using several innovative approaches to study endometriosis and other women's reproductive health disorders. In this episode Dr. Metz and Dr. Gregersen joined me to discuss the exciting horizon of a new painless diagnostic test for endometriosis they are currently developing. We dug deep on so many fascinating questions from the genetics of endometriosis to if it really is an autoimmune disorder or something else entirely. If you have an endo diagnosis, infertility, or suspect endo this really is theepisode for you! Happy Endo Awareness Month! ---Join the ROSE Study and help future endo warriors!Join our Beyond Endo Support GroupGet transcripts and more at beyondendo.comThis podcast uses the following third-party services for analysis: Chartable - https://chartable.com/privacy

A talented, qualified, engaged and diverse workforce is at the heart of America's health care system. But hospitals and health systems face mounting and critical staffing shortages that could jeopardize access to care in the communities they serve. As hospitals struggle to retain and support an exhausted workforce they are left looking for unique ways to better support and enhance resilience among clinicians and to address the traumatic stress caused by COVID-19. In today's episode Elisa Arespacochaga, AHA vice president of clinical affairs and workforce, sits down with Dr. Rebecca Schwartz, associate professor and chief of Social Behavioral Sciences at the Department of Occupational Medicine and Epidemiology and Prevention, associate investigator at the Feinstein Institutes for Medical Research and director of Research and Evaluation at the Center for Traumatic Stress, Resilience and Recovery at Northwell Health, as well as Dr. Mayer Bellehsen, director of Behavioral Health at the Center for Traumatic Stress, Resilience and Recovery at Northwell Health and Mildred and Frank Feinberg Division of the Unified Behavioral Health Center for Military Veterans and Their Families to talk about the Center for Traumatic Stress, Resilience and Recovery at Northwell Health.

In this week's special episode of The Weekly Dose Podcast we interview Dr Tobias Janowitz, a medical oncologist, assistant professor at the Cold Spring Harbor Laboratories and adjunct professor at the Feinstein Institutes. Dr Janowitz was part of a team that recently conducted a phase 2 clinical trial assessing high doses of famotidine in adults with COVID-19. The trial was conducted completely remotely and the findings were published in Gut. As well as discussing their findings, Dr Janowitz talks about the process of conducting a fully-remote trial and the greater possibilities this may hold for future clinical research.

Researchers have identified more than 200 symptoms associated with the long-term effects of Covid-19, but much remains unknown. Peter Silver, MD and Sonali Narain, MD shed light on some of the mysteries that surround long Covid, also known as post-acute sequelae of SARS-CoV-2 (PASC). They offer context to the current state of the disease and actions being taken by the medical and research communities to combat and better understand it. Meet the experts Peter Silver, MD is the Chief Quality Officer at Northwell Health. He is responsible for system-wide initiatives in care quality and patient safety. Sonali Narain, MD is a Director of the Scleroderma and Raynaud Treatment Center and the Epidemiology division of Rheumatology. She is also an assistant professor at the Feinstein Institutes for Medical Research and Director of the Northwell Health CARES Learning Collaborative. The CARES program is model designed to increase patient access across treatment areas and amplify a patient-centered experience. 

Bloomberg News Senior Editor Ethan Bronner reports on how the invasion of Ukraine is causing a mass exodus of companies from Russia, reversing three decades of investment by Western and other foreign businesses. Dr. Kevin Tracey, CEO of the Feinstein Institutes for Medical Research, explains how Pepcid can help fight Covid. Bloomberg Businessweek Editor Joel Weber and Bloomberg News Video Game Reporter Cecilia D'Anastasio share the details of Cecilia's Businessweek Magazine story Crypto Poker Is What Everyone Is Doing in the Metaverse. And we Drive to the Close with Ella Hoxha, Senior Investment Manager at Pictet Asset Management Hosts: Carol Massar and Tim Stenovec. Producer: Paul Brennan. Learn more about your ad-choices at https://www.iheartpodcastnetwork.com

Bloomberg News Senior Editor Ethan Bronner reports on how the invasion of Ukraine is causing a mass exodus of companies from Russia, reversing three decades of investment by Western and other foreign businesses. Dr. Kevin Tracey, CEO of the Feinstein Institutes for Medical Research, explains how Pepcid can help fight Covid. Bloomberg Businessweek Editor Joel Weber and Bloomberg News Video Game Reporter Cecilia D'Anastasio share the details of Cecilia's Businessweek Magazine story Crypto Poker Is What Everyone Is Doing in the Metaverse. And we Drive to the Close with Ella Hoxha, Senior Investment Manager at Pictet Asset Management Hosts: Carol Massar and Tim Stenovec. Producer: Paul Brennan. See omnystudio.com/listener for privacy information.

This Valentine's Day we're celebrating a love for science and a special bond between two scientists. Kim Simpfendorfer, PhD, and Michael Ryan built a relationship while pursuing a career at the Feinstein Institutes for Medical Research. They also discuss their experience of going through in-vitro fertilization, pregnancy, and the crucial role the Covid vaccine played in building their family. Sarah Pachtman, MD, a maternal/fetal medicine doctor explains what other couples should know about IVF and how partners can provide support.

Duane Peters from the Lupus Foundation of America interviews Dr Erik Anderson and Dr Meggan Mackay from the Feinstein Institutes for Medical Research in New York in the USA. They discuss their study into imbalances in quinolinic acid and kynurenic acid levels in the brain in SLE patients, and propose that the ratio between these two metabolites could be used as a new biomarker or therapeutic target for cognitive dysfunction. Access the paper here: https://lupus.bmj.com/content/8/1/e000559

The advent of the Covid-19 vaccines propelled us into 2021 and put a spotlight on the critical role of research and clinical trials. In this episode we spotlight five innovations coming out of the last year from researchers at the Feinstein Institutes for Medical Research. The innovations aim to improve life for patients living with paralysis, schizophrenia, cardiovascular disease, Covid-19, brain cancer and PTSD.   Chapters:   00:42 – Treating PTSD with inner-ear stimulation – Dr. Rebecca Schwartz and Dr. Theodoros Zanos  04:13 – Virtual trials – Dr. Christina Brennan and Dr. Mark Butler  08:30 – Artificial intelligence to help diagnose schizophrenia – Dr. Sunny Tang  11:17 – Restoring movement in paralyzed patients – Chad Bouton   13:30 – Treating glioblastoma with belly fat – Dr. John Boockvar    16:33 – Northwell's Top 5 moments in 2021   In a bonus segment, we reflect on Northwell Health's most newsworthy moments, including the release of The First Wave Documentary; the Northwell Health Nurse Choir competes on America's Got Talent; the 20th anniversary of 9/11; the authorization on Covid-19 vaccinations for children; and the anniversary of the first Covid-19 vaccination in the U.S.     Meet our guests:  Rebecca Schwartz, PhD, associate investigator, Institute of Health System Science at Feinstein Institutes and Director, Research and Evaluation, Northwell Center for Traumatic Stress, Resilience and Recovery  Theodoros Zanos, PhD, assistant professor, Institute of Bioelectronic Medicine, Feinstein Institutes for Medical Research and Assistant Professor, Molecular Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell  Christina Brennan, MD, MBA, vice president of clinical research at Northwell Health's Feinstein Institutes for Medical Research  Mark Butler, PhD, assistant investigator, Center for Personalized Health, Feinstein Institutes for Medical Research  Sunny Tang, MD, assistant professor, Institute of Behavioral Science, Feinstein Institutes for Medical Research and Assistant Professor, Department of Psychiatry, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell  Chad Bouton, professor, Institute of Bioelectronic Medicine, Feinstein Institutes for Medical Research, Vice President, Advanced Engineering, Northwell Health, and Professor, Molecular Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell  John Boockvar, MD, professor, Feinstein Center for Neuroscience and Laboratory for Brain Tumor Biology and Therapy, Feinstein Institutes for Medical Research, Co-Director, Brain Tumor Biotech Center, Feinstein Institutes for Medical Research, and Vice Chair, Department of Neurosurgery, Lenox Hill Hospital   Watch episodes of 20-Minute Health Talk on YouTube. 

Well Said has invited Dr. Edith Burns, Professor of Medicine in the Division of Geriatrics and Palliative Medicine at the Donald and Barbara Zucker School of Medicine as well as the Institute of Health System Science at the Feinstein Institutes and Director of Research of the Division of Geriatrics and Palliative Medicine to discuss active aging and what we can do to avoid or delay the disability that many associate with getting older.

The HealthyWomen 2021 Survey reveals that moms still feel pressured to ‘do it all' and continue to deprioritize their mental health and well-being.  Ummmm. . .we needed a study to find that out?! In all seriousness, research shows that women are more likely to experience postpartum depression (PPD) if they receive little or no support from family, friends, or community after childbirth than women who receive appropriate support. With 1 in 8 mothers in the U.S. reporting experiencing symptoms of postpartum depression (PPD) each year, there is a need for greater fourth trimester (the 12 weeks following baby's arrival) planning and support. So what are we going to do about it?  Check on Mom https://www.mycheckonmom.com is a program to help new and expectant moms create a maternal mental wellness plan and designate a group of trusted friends and family who are empowered to help her through the postpartum period. The site also features ongoing inspirational content and helpful information and tips. Here to discuss this with us today is Dr. Kristina Deligiannidis, Director, Women's Behavioral Health of Northwell Health.  Dr. Deligiannidis is a national leader in the field of perinatal depression and novel therapeutics research. Her research program includes a focus in psychoneuroendocrinology, particularly neurosteroids and hormones, and neuroimaging in women's behavioral health. She has authored more than 50 peer-reviewed articles plus several textbook chapters and has given more than 170 scientific presentations.   Dr. Deligiannidis completed her undergraduate degrees in biology and psychology at the University of Massachusetts at Amherst. As a recipient of predoctoral intramural research training awards, she trained in molecular neuroendocrinology research at the National Institutes of Health (NIH) and the National Institute of Mental Health (NIMH). She received her medical degree from and completed her psychiatry residency and chief residency in psychopharmacology research at the University of Massachusetts Medical School. After residency, she completed a visiting fellowship and further training in multimodal neuroimaging at the Massachusetts General Hospital/Martinos Center for Biomedical Imaging. Dr. Deligiannidis joined faculty at Zucker Hillside Hospital, the Feinstein Institutes for Medical Research and the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell in September 2016. She is board certified by the American Board of Psychiatry and Neurology and currently serves as the director of women's behavioral health at Zucker Hillside Hospital. As a reproductive psychiatrist, she has expertise in treating women with mood and anxiety disorders linked to the menstrual cycle, pregnancy/postpartum and perimenopause.

To celebrate the approach of ACR 2021, we are releasing the ACR 2020 Mentor Mentee Meeting Podcasts. In this episode, Dr Alvise Berti interviews Prof. Betty Diamond, joined by fellows from basic science and medical/rheumatology worlds, discussing the development of her career as a physician-scientist. Prof. Diamond graduated with a BA from Harvard University and an MD from Harvard Medical School. She performed a residency in internal medicine at Columbia Presbyterian Medical Center and received postdoctoral training in immunology at the Albert Einstein College of Medicine. Prof. Diamond has headed the rheumatology divisions at Albert Einstein School of Medicine and at Columbia University Medical Center. She also directed the Medical Scientist Training Program at Albert Einstein School of Medicine for many years. She is currently head of the Center for Autoimmune, Musculoskeletal and Hematopoietic Diseases at The Feinstein Institutes for Medical Research and director of the PhD and MD/PhD programs of the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. A former president of the American Association of Immunology, Prof. Diamond has also served on the Board of Directors of the American College of Rheumatology and the Scientific Council of the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). Here, she shares some of her experiences in the field of medical research, especially in lupus, challenges she has faced, and valuable insights into life as an academic clinician.

Common COVID-19 symptoms include fever, chills, cough and shortness of breath. But research has revealed that a surprising number of older adults experience some atypical signs of the virus. This is according to a study published in the Journal of Gerontology. The principal investigator of that paper, Allison Marzilliano, PhD, discusses her findings and their implications for older adults and clinicians.  Dr. Marziliano is assistant professor in the Center for Health Innovations and Outcomes Research for the Feinstein Institutes for Medical Research. Chapters: 00:29 - What are atypical COVID-19 symptoms? 01:24 - About the study 02:33 - Key takeaways 04:40 - What is functional decline?  05:43 - Testing older adults for COVID-19 07:34 - Comparing outcomes in typical, atypical patients 09:21 - Explaining atypical COVID-19 symptoms 11:07 - Dementia and COVID-19 11:25 - Northwell Health older adult workgroup 13:21 - Future COVID-19 research 15:24 - Isolation during COVID-19 16:00 - Ageism in healthcare research 18:14 - Role of COVID-19 vaccines 18:54 - On a positive note Watch episodes of 20-Minute Health Talk on YouTube. 

There are many misconceptions about postpartum depression, what it is, and how it manifests itself. This episode will clear up some of the myths and bring clarity, hope, and awareness to this topic. Join us to learn more! Kristina Deligiannidis, MD, received her medical degree from and completed her psychiatry residency and chief residency in psychopharmacology research at the University of Massachusetts Medical School. After residency, she completed a visiting fellowship and further training in multimodal neuroimaging at the Massachusetts General Hospital/Martinos Center for Biomedical Imaging. Dr. Deligiannidis joined the faculty at Zucker Hillside Hospital, the Feinstein Institutes for Medical Research, and the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell in September 2016. She is board certified by the American Board of Psychiatry and Neurology and currently serves as the director of women's behavioral health at Zucker Hillside Hospital. As a reproductive psychiatrist, she has expertise in treating women with mood and anxiety disorders linked to the menstrual cycle, pregnancy, postpartum, and perimenopause.  Show Highlights: How Dr. D came to this field that blends neuroscience, psychiatry, and women's health Why her research into postpartum depression focuses on the female hormones before, during, and after pregnancy and childbirth Postpartum depression defined and explained: It is a mix of emotional, physical, and other symptoms that usually begin with sadness, loss of pleasure in activities, sleep difficulties, appetite disturbances, irritability, agitation, guilt, loss of worth, and more. How postpartum depression and “baby blues” differ in severity, onset, and duration How changes in the brain take place due to pregnancy hormones increasing and decreasing with the birth process Risk factors for perinatal depression include a personal history of depression, increased stressors, and minimal support How moms describe postpartum depression with feelings of isolation and a loss of self How many women suffer without getting the help and support they need and have long-term effects Why we need to do a better job in recognizing and treating postpartum depression for the sake of moms, babies, families, and society How the risks for depression in pregnancy and the postpartum can differ from each other D explains a recent study by Healthy Woman that shows the pressure women feel to “do it all” and like they are “bothering someone” if they ask for help How people can prepare for life with a new baby and prioritize their emotional health Why a higher percentage of Hispanic and black women report inadequate social support and poor access to their healthcare providers in the early postpartum period, as compared with white women How a new program, Check On Mom, helps with developing a maternal mental wellness plan Resources: My Check On Mom  Connect with Kristina

Well Said has invited Dr. Daniel Grande is the Assistant Vice President of Research Services at the Feinstein Institutes for Medical Research, at Northwell Health. He is also a Professor of Molecular Medicine and Orthopedic Surgery and within the Institute of Bioelectronic Medicine at the Zucker School of Medicine at Hofstra/Northwell and Feinstein Institutes for Medical Research.to talk about 3D bioprinting, a way of creating three-dimensional structures out of living tissue or biological material.

Thanks to improvements in breast cancer screening and treatment, more than 80 percent of patients will beat the disease. But, survivorship comes with its own health challenges — something  health professionals and patients need to start planning for at diagnosis, says Catherine Alfano, PhD, an international leader in cancer survivorship and rehabilitation. She joins medical oncologist Jennifer Ligibel, MD, and integrative health and wellness coach Deborah McElligott, NP, to discuss the challenges of implementing this approach; the issues cancer survivors face; and balancing the benefits and long-term risks of cancer treatments.  Chapters: 00:01 - Survivorship starts at diagnosis 01:20 - What is survivorship? 03:24 - Cancer care and lifestyle changes 05:27 - American Society of Clinical Oncology (ASCO) 07:15 - Getting survivorship right 08:40 - Cancer treatments: balancing benefits and risks 09:09 - Integrative medicine programs 11:34 - Tai chi health benefits 12:21 - Cancer care and integrative health 14:03 - Cancer research and personalized care 15:18 - What is a learning health system? 16:01 - Breast cancer survivor 18:34 - Racial disparities in survivorship 19:36 - Support from faith-based communities Meet the experts Catherine Alfano, Ph.D., is vice president of cancer care management and research at the Northwell Health Cancer Institute, and associate director for the Institute of Health System Science at the Feinstein Institutes for Medical Research. She also co-chairs the American Society of Clinical Oncology's clinical guidelines on nutrition, physical activity, and weight management for treatment in cancer patients. Previously, she served as vice president for survivorship at the American Cancer Society; and before that as deputy director of the office of cancer survivorship at the National Cancer Institute. Jennifer Ligibel, MD, is a medical oncologist and director of the Leonard P. Zakim Center for Integrative Therapies and Healthy Living at the Dana Farber Cancer Institute. She also co-chairs the American Society of Clinical Oncology's clinical guidelines on nutrition, physical activity, and weight management for treatment in cancer patients. Deborah McElligott, DNP, is a holistic nurse practitioner, as well as an integrative health and wellness coach at the Center for Wellness and Integrative Medicine at the Katz Institute for Women's Health.

A total of 1,151 patients required mechanical ventilators. Of the 320 for whom final outcomes are known (either death or discharge), 88 percent died. That compares with about 80 percent of patients who died on ventilators before the pandemic, according to previous studies — and with the death rate of about 50 percent that some critical-care doctors had optimistically hoped for when the first cases were diagnosed. “For those who have a severe enough course to require hospitalization through the emergency department, it is a sad number,” said Karina W. Davidson, the study's lead author and a professor at the Feinstein Institutes for Medical Research at Northwell Health. --- Send in a voice message: https://anchor.fm/david-ostrowski/message

The COVID-19 vaccines have put a spotlight on the importance of clinical trials. During the early days of the pandemic in New York, researchers like John Boockvar, MD, had to shut down ongoing trials to contribute to the fight against the novel virus. Since, he has resumed his work investigating novel approaches to treating brain cancers. He has been internationally recognized for his research in brain tumors and stem cell biology throughout his 20-year career. He explains the importance of clinical trials, his connection with the inventor of mRNA technology, and his experience leading investigations into experimental treatments for glioblastomas — the deadliest form of brain cancer.   Meet the expert Dr. Boockvar is a world-renowned brain tumor expert. He is vice chair of neurosurgery and director of the Brain Tumor Center at Lenox Hill; and director of the Laboratory for Brain Tumor Biology and Therapy at the Feinstein Institutes for Medical Research.  Along with his fellow neurosurgeons, he was the subject of the highly-acclaimed Netflix docudrama in 2020, “Lenox Hill.” 

Dr. Kevin Tracey, CEO of the Feinstein Institutes for Medical Research, discusses the need for developing more treatments for COVID-19 and other viruses. Bloomberg Opinion Politics Columnist Jonathan Bernstein explains why getting an infrastructure deal wasn't simple. Chainalysis CEO Michael Gronager talks about raising $100 million in funding for the blockchain analysis company. And we Drive to the Close with Christian Munafo, CIO at Liberty Street Advisors.  Hosts: Carol Massar and Tim Stenovec. Producer: Paul Brennan. Learn more about your ad-choices at https://www.iheartpodcastnetwork.com

Dr. Kevin Tracey, CEO of the Feinstein Institutes for Medical Research, discusses the need for developing more treatments for COVID-19 and other viruses. Bloomberg Opinion Politics Columnist Jonathan Bernstein explains why getting an infrastructure deal wasn't simple. Chainalysis CEO Michael Gronager talks about raising $100 million in funding for the blockchain analysis company. And we Drive to the Close with Christian Munafo, CIO at Liberty Street Advisors.  Hosts: Carol Massar and Tim Stenovec. Producer: Paul Brennan. Learn more about your ad-choices at https://www.iheartpodcastnetwork.com

Eric Chang is a Neuroscientist and Assistant Professor at the Institutes of Bioelectronic Medicine and Molecular medicine at the Feinstein Institutes of medical research at Northwell Health. His areas of interests are Neuro-immunology, electrophysiology, microscopy and bioengineering. In today’s episode, Eric talks to us about his work with the vagus nerve and approaches being used in his lab to understand signalling between the nervous system and immune system.   Top three takeaways: We haven't got technology that can image individuals neurons connected to the vagus nerve but in the near future, the tools might evolve to do this. Recording neural signals in different patients lets you see different types of variations across patients and informs how you design treatments based on that person’s neurobiology. “There are the traditional senses that are related to exteroception, like sight, sound, smell, touch, and taste. There's a plethora of as I mentioned, interoceptive signals as well that have to do with organ function.”   [0:00] Ladan introduces the episode and the guest, Eric Chang   [1:50] Eric Chang introduces himself and his work. His lab is interested in finding the connection between the nervous system and immune system   [3:45] How is imaging different from electrophysiology and what are the advantages and disadvantages of both?   [6:10] “So I would say patch-clamp electrophysiology, which is patching a single cell with a glass pipette, is still the gold standard, but the tools are rapidly coming to the fore that are starting to replace that a little bit.”   [11:20]  Eric talks about some of the challenges with imaging individual neurons connected to the vagus nerve, especially where there is a lot of movement.   [12:50]  While the technology is quite small now, it’s not so small that it could quite fit into a necklace. Eric believes that somewhere in the next 5 - 10 years, something of the sort will be available.   [13:40] “Dr Tracey's work from two decades ago showed the discovery of something called the inflammatory reflex which is that If you electrically stimulate the vagus nerve under conditions of inflammation, let's say acute endotoxemia, then you can reduce levels of circulating pro-inflammatory cytokines”   [20:00] Eric discusses some of the tools used to tease apart different signals.   [23:05] Eric talks about some future breakthroughs he expects.   [27:00] “Yeah. So the nerve innervation exists for protection; it's for survival. We need to know when we're getting close to a fire”   [28:00] Eric talks about the importance of understanding pain.   [31:00] “There are the traditional senses that are related to exteroception, like sight, sound, smell, touch, and taste. There's a plethora of as I mentioned, interoceptive signals as well that have to do with organ function.”

Dr. Boockvar is Vice-Chair Department of Neurosurgery & Director Brain Tumor and Pituitary/Neuroendocrine Center at Lenox Hill Hospital/Northwell Health in New York City. He is also an Investigator for Laboratory for Brain Tumor Biology at the Feinstein Institutes for Medical Research. He is internationally known for his surgical expertise and for providing patients with safe, effective, and minimally invasive treatment for brain tumors, skull base disorders, and disorders of the spine. He is currently featured as one of four doctors in the 2020 hit docuseries “Lenox Hill”  Season 1 on Netflix.     For resource articles and other information please visit: TheGameOnGlioPodcast.com BrainsForTheCure.org

Well Said has invited Dr. Kevin Tracey, President and CEO of the Feinstein Institutes of Medical Research and Professor of Molecular Medicine and Neurosurgery at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell to discuss the growing field of bioelectronics, a fascinating new field that brings together a wide variety of disciplines, including human biology, electrical engineering, and clinical medicine. Receive Well Said Radio Show UpdatesGet notifications about upcoming shows, topics and guests directly to your inbox. Never miss an episode! Send us feedback and much more. Email (required) *First Name Last Name Select list(s) to subscribe toWellSaid-2020 Yes, I would like to receive emails from Well Said. (You can unsubscribe anytime)Constant Contact Use. Please leave this field blank.By submitting this form, you are consenting to receive marketing emails from: Donald and Barbara Zucker School of Medicine, 500 Hofstra University, Hempstead, NY, 11549, http://medicine.hofstra.edu/. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contactvar ajaxurl = "https://sites.hofstra.edu/wellsaid/wp-admin/admin-ajax.php";

March is endometriosis awareness month. Endometriosis is estimated to affect 1 in 9 women. It can cause physical issues such as pelvic pain and infertility, psychological pain, and functional limitations as well. The pathophysiology of this disease isn't completely clear, but it's important that women are diagnosed in an efficient manner and have access to skilled medical and rehab providers who can help them with proficient treatment. Truthfully, it takes a team of providers working together to treat the person comprehensively. Today we will be talking with Dr. Shrikhande of Pelvic Rehabilitation Medicine. Pelvic Rehabilitation Medicine provides an advanced model of care for treating pelvic pain conditions centered around treating the person and not just the symptoms. Their network of providers include overseeing physicians, surgeons, nutritionists, mental health, and rehab providers. Dr. Allyson Shrikhande, is a board certified Physical Medicine and Rehabilitation specialist and is the Chief Medical Officer of Pelvic Rehabilitation Medicine. She is also the Chair of the Medical Education Committee for the International Pelvic Pain Society. Links: The ROSE Trial (Research OutSmarts Endometriosis study by Feinstein Institutes for Medical Research)ICareBetter.com (find an endometriosis expert)Retrain Your Brain (online course by Dr. Sckrivani) 

We sit down for an interview with Dr. John Boockvar, vice chair of neurosurgery at Lenox Hill Hospital, who started a first-in-human clinical research study involving a new surgical technique to treat glioblastoma multiforme (GBM) - the most aggressive form of brain cancer.   Dr. Boockvar was one of the neurosurgeons featured on the highly praised Netflix series, Lenox Hill. See link here: https://www.netflix.com/title/80201728   About the Procedure: After standard tumor resection, the patient's own scalp tissue is harvested, rotated and engrafted and used to line the resected tumor cavity. It is our hope that by doing tissue autograft, it will allow to bypass the blood brain barrier so chemotherapeutics and immune cells can better reach the tumor site, improving treatment for GBM patients. The study entitled, "Tissue Autograft to Bypass the Blood Brain Barrier (BBB) in Human Glioblastoma Multiforme," is being led by John Boockvar, MD, the hospital's vice chair, neurosurgery and director of Lenox Hill's Brain Tumor Center. To be eligible for the study, participants must be 18 years of age or older and plan to undergo resection of known or suspected GBM. Press release about the first patient for further background: https://www.northwell.edu/news/lenox-hill-first-to-study-using-tissue-autograft-for-gbm-tumors-in-humans Lenox Hill's neurosurgery department webpage: https://lenoxhill.northwell.edu/neurosurgery Social Media: Instagram: lhh_neurosurgery Twitter: @LenoxNeurosurg Dr. Boockvar, background link: https://www.northwell.edu/about/leadership/john-andrew-boockvar-md Dr. Boockvar's research at the Feinstein Institutes for Medical Research: https://feinstein.northwell.edu/institutes-researchers/our-researchers/john-boockvar-md

Dr. Kevin Tracey, CEO at Feinstein Institutes for Medical Research, provides a coronairus and vaccine update. Bloomberg Businessweek Editor Joel Weber and Businessweek Economics Editor Peter Coy talk about the story “The 1920s Roared After a Pandemic, and the 2020s Will Try.” Carnival Corporation CEO Arnold Donald joins from the Bloomberg The Year Ahead virtual event to discuss managing through the pandemic and the outlook for cruise ships. And we Drive to the Close with Ryan Detrick, Senior Market Strategist at LPL Financial. Hosts: Carol Massar and Tim Stenovec. Producer: Doni Holloway. Learn more about your ad-choices at https://www.iheartpodcastnetwork.com

Dr. Negin Hajizadeh discussing Feinstein Institutes researchers finding an effective COVID-19 ‘cytokine storm' treatment and more. Dr. Hajizadeh is an ICU pulmonologist and was a part of Northwell Health's, NY largest health system, at the height of the surge. She has experienced and delivered care first hand. She is also a researcher with the Feinstein Institutes. #Recovery trial #Covid-19

Dr. Richard Furie discuss his recent involvement with the Phase 3 BLISS-LN clinical trial that is setting the stage for the first ever FDA approved drug for lupus nephritis. Dr. Furie is a professor at the Feinstein Institutes for medical research, Northwell Health's science arm of the health system. Regarded as one the senior rheumatologists in the New York metropolitan area, he has been on the Boards of Directors of the local chapters of the Arthritis Foundation and the Lupus Alliance of America and has been a member of the Medical-Scientific Advisory Council of the Lupus Foundation of America as well as its Lupus News editorial board. He also is on the Medical and Scientific Advisory Board of the SLE Foundation as well as the Alliance for Lupus Research Scientific Advisory Board.

Thomas McGinn, MD, is the Chair and Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. He serves as the Director and Professor at the Institute of Health Innovations & Outcomes Research at the Feinstein Institutes for Medical Research. Dr. McGinn also holds the office of Senior Vice President and Executive Director of Medicine Service Line at Northwell Health. Teaching trainees at multiple levels, Dr. McGinn is a huge proponent of mentorship, continually mentoring students, residents, and faculty at Northwell and beyond. He strongly supports the innovative ideas and research stemming from the talented young minds of tomorrow's healthcare leaders. He has been the recipient of several NIH-funded grants and effectively executed numerous research studies. He has authored and published more than one hundred research papers. Dr. McGinn is also the author of the clinical prediction rules chapter of the JAMA series Users' Guides to Medical Literature. First step: Get clear on what your goals are. After that? Recognize the opportunities that lead you closer to your goals—and let go of the rest. Dr. Thomas McGinn believes in strategizing when it comes to success: With every opportunity that comes our way, there is a cost to consider. Hard work, says Dr. McGinn, does not magically equal success. Instead, we must plan ahead, especially in academic careers. Success is also derived from supporting—and celebrating—the joy that comes from helping others achieve their full potential. Pearls of Wisdom: 1. Being proactive in reaching out to your mentors, that is the key to a successful mentor/mentee relationship. 2. Having a cost effective approach in taking up opportunities and know when to say no to which opportunity. 3. Be cognitively strategic about your own personal success. Hard work alone will not suffice.